<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0223523416307103</prism:url><dc:identifier>doi:10.1016/j.ejmech.2016.08.055</dc:identifier><eid>1-s2.0-S0223523416307103</eid><prism:doi>10.1016/j.ejmech.2016.08.055</prism:doi><pii>S0223-5234(16)30710-3</pii><dc:title>Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors </dc:title><prism:publicationName>European Journal of Medicinal Chemistry</prism:publicationname><prism:aggregationType>Journal</prism:aggregationtype><pubType>fla</pubtype><prism:issn>02235234</prism:issn><prism:volume>124</prism:volume><prism:startingPage>896</prism:startingpage><prism:endingPage>905</prism:endingpage><prism:pageRange>896-905</prism:pagerange><dc:format>text/xml</dc:format><prism:coverDate>2016-11-29</prism:coverdate><prism:coverDisplayDate>29 November 2016</prism:coverdisplaydate><prism:copyright>© 2016 Elsevier Masson SAS. All rights reserved.</prism:copyright><prism:publisher>Elsevier Masson SAS.</prism:publisher><dc:creator>Phuangsawai, Oraphan</dc:creator><dc:creator>Beswick, Paul</dc:creator><dc:creator>Ratanabunyong, Siriluk</dc:creator><dc:creator>Tabtimmai, Lueacha</dc:creator><dc:creator>Suphakun, Praphasri</dc:creator><dc:creator>Obounchoey, Phongphat</dc:creator><dc:creator>Srisook, Pimonwan</dc:creator><dc:creator>Horata, Natharinee</dc:creator><dc:creator>Chuckowree, Irina</dc:creator><dc:creator>Hannongbua, Supa</dc:creator><dc:creator>Ward, Simon E.</dc:creator><dc:creator>Choowongkomon, Kiattawee</dc:creator><dc:creator>Gleeson, M. Paul</dc:creator><dc:description>
                  A series of 2,4 diamino-pyrimidines have been identified from an analysis of open access high throughput anti-malarial screening data reported by GlaxoSmithKline at the 3D7 and resistant Dd2 strains. SAR expansion has been performed using structural knowledge of the most plausible parasite target. Seventeen new analogs have been synthesized and tested against the resistant K1 strain of Plasmodium falciparum (Pf). The cytotoxicity of the compounds was assessed in Vero and A549 cells and their selectivity towards human kinases including JAK2 and EGFR were undertaken. We identified compound 5n and 5m as sub-micromolar inhibitors, with equivalent anti-malarial activity to Chloroquine (CQ). Compounds 5d and 5k, μM inhibitors of Pf, displayed improved cytotoxicity with weak inhibition of the human kinases.
               </dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessarticle><openaccessType/></openaccesstype><openArchiveArticle>false</openarchivearticle><openaccessSponsorName/></openaccesssponsorname><openaccessSponsorType/></openaccesssponsortype><openaccessUserLicense/></openaccessuserlicense><dcterms:subject>2,4-Diaminopyrimidine</dcterms:subject><dcterms:subject>Plasmodium falciparum</dcterms:subject><dcterms:subject>Antimalarials</dcterms:subject><dcterms:subject>Drug design</dcterms:subject><dcterms:subject>Tyrosine kinase inhibitors</dcterms:subject><dcterms:subject>K1 strain</dcterms:subject><dcterms:subject>JAK2 kinase</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S0223523416307103" rel="self"/></link><link href="https://www.sciencedirect.com/science/article/pii/S0223523416307103" rel="scidir"/></link></coredata><objects><object ref="fx1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="96" size="23343">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-fx1.sml?httpAccept=%2A%2F%2A</object><object ref="fx2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="140" size="10711">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-fx2.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="207" height="164" size="12187">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="94" size="22561">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="sc1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="81" size="8148">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-sc1.sml?httpAccept=%2A%2F%2A</object><object ref="sc2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="47" size="7299">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-sc2.sml?httpAccept=%2A%2F%2A</object><object ref="fx1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="456" height="200" size="70432">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-fx1.jpg?httpAccept=%2A%2F%2A</object><object ref="fx2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="150" height="96" size="21201">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-fx2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="511" height="405" size="54650">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="535" height="230" size="84363">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="sc1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="512" height="188" size="29845">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-sc1.jpg?httpAccept=%2A%2F%2A</object><object ref="sc2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="667" height="142" size="28644">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-sc2.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2021" height="886" size="387880">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-fx1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="665" height="425" size="45656">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-fx2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2264" height="1795" size="297326">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2370" height="1020" size="523081">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="sc1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2266" height="834" size="128018">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-sc1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="sc2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2953" height="629" size="128420">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-sc2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="mol" category="standard" type="APPLICATION" multimediatype="ZIP file" mimetype="application/zip" size="8308">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-mol.zip?httpAccept=%2A%2F%2A</object><object ref="mmc1" category="standard" type="APPLICATION" multimediatype="Microsoft Word file" mimetype="application/word" size="1335081">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416307103-mmc1.docx?httpAccept=%2A%2F%2A</object></objects><scopus-id>84988526111</scopus-id><scopus-eid>2-s2.0-84988526111</scopus-eid><pubmed-id>27668758</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/84988526111" rel="abstract"/></link><originalText><xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271932</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291732</xocs:ssid>
         <xocs:ssid type="subj">291789</xocs:ssid>
         <xocs:ssid type="subj">291858</xocs:ssid>
         <xocs:ssid type="subj">291928</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>European Journal of Medicinal Chemistry</xocs:srctitle>
      <xocs:normalized-srctitle>EUROPEANJOURNALMEDICINALCHEMISTRY</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20160830">2016-08-30</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20160830">2016-08-30</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20160924">2016-09-24</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20160924">2016-09-24</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2017-09-18T10:08:57</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S0223523416307103</xocs:eid>
      <xocs:pii-formatted>S0223-5234(16)30710-3</xocs:pii-formatted>
      <xocs:pii-unformatted>S0223523416307103</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.ejmech.2016.08.055</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.3</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0223523416X00165</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20170918">2017-09-18T15:25:25.753803-04:00</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20161129</xocs:date-search-begin>
      <xocs:year-nav>2016</xocs:year-nav>
      <xocs:indexeddate epoch="1472561531">2016-08-30T12:52:11.373411Z</xocs:indexeddate>
      <xocs:articleinfo>absattachment articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast grantnumber grantsponsor grantsponsorid highlightsabst otherkwds primabst pubtype ref specialabst</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0223-5234</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>02235234</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>124</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>124</xocs:volume>
      </xocs:volume-list>
      <xocs:suppl>C</xocs:suppl>
      <xocs:vol-iss-suppl-text>Volume 124</xocs:vol-iss-suppl-text>
      <xocs:sort-order>63</xocs:sort-order>
      <xocs:first-fp>896</xocs:first-fp>
      <xocs:last-lp>905</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>896</xocs:first-page>
         <xocs:last-page>905</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20161129</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>29 November 2016</xocs:cover-date-text>
      <xocs:cover-date-start>2016-11-29</xocs:cover-date-start>
      <xocs:cover-date-year>2016</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Original articles</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>© 2016 Elsevier Masson SAS. All rights reserved.</xocs:copyright-line>
      <xocs:normalized-article-title>EVALUATIONANTIMALARIALACTIVITYCYTOTOXICITY24DIAMINOPYRIMIDINEBASEDKINASEINHIBITORS</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>PHUANGSAWAI</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>O</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Results</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Design</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Synthesis</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Biological testing</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.3.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Anti-malarial activity</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.3.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Cytotoxicity</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>2.3.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Protein kinase activity</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Conclusions</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Experimental details</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemistry</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Preparation of anilines <ce:bold>3a–c</ce:bold>
               </xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-Methyl-4-(4-methylpiperazin-1-yl)aniline (<ce:bold>3a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(4-Methylpiperazin-1-yl)aniline (<ce:bold>3b</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-(Morpholin-4-yl)aniline (<ce:bold>3c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>General procedure for the preparation of intermediate compounds <ce:bold>4a–e</ce:bold>
               </xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-[(2-Chloro-5-cyano-pyrimidin-4-yl)amino]benzamide (<ce:bold>4a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[(2-Chloro-5-cyano-pyrimidin-4-yl)amino]benzenesulfonamide (<ce:bold>4b</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[(4-Chloro-5-cyano-pyrimidin-4-yl)amino]benzenesulfonamide (<ce:bold>4c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-Chloro-4-(3-methylsulfonylanilino)pyrimidine-5-carbonitrile (<ce:bold>4d</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.5</xocs:item-toc-label>
                  <xocs:item-toc-section-title>
                     <ce:italic>N</ce:italic>-<ce:italic>tert</ce:italic>-butyl-3-[(2-chloro-5-cyano-pyrimidin-4-yl]benzenesulfonamide (<ce:bold>4e</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>General procedure for the preparation of intermediate compounds <ce:bold>4f</ce:bold>
               </xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.4.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[(2-Chloro-5-methoxypyrimidin-4-yl)amino]benzene-1-sulfonamide (<ce:bold>4f</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>General procedure for the preparation of compounds <ce:bold>4g–4i</ce:bold>
               </xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.5.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-[(2-Chloropyrimidin-4-yl)amino]benzamide (<ce:bold>4g</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.5.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[(2-Chloropyrimidin-4-yl)amino]benzenesulfonamide (<ce:bold>4h</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.5.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-Chloro-<ce:italic>N</ce:italic>-(3-methylphenyl)pyrimidin-4-amine (<ce:bold>4i</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>General procedure for the synthesis of compound <ce:bold>1a</ce:bold>, <ce:bold>5a–d</ce:bold>
               </xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.6.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-[[5-Cyano-2-[3-methyl-4-(4-methylpiperazin-1-yl)aniline]pyrimidin-4-yl]amino]benzamide (<ce:bold>1a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.6.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[[5-Cyano-2-[3-methyl-4-(4-methylpiperazin-1-yl)aniline]pyrimidin-4-yl]amino]benzenesulfonamide (<ce:bold>5a</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.6.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[[5-Cyano-4-[3-methyl-4-(4-methylpiperazin-1-yl)aniline]pyrimidin-2-yl]amino]benzenesulfonamide (<ce:bold>5b</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.6.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-[3-Methyl-4-(4-methylpriperazin-1-yl)aniline]-4-(3-methylsulfonylanilino)pyrimidine-5-carbonitrile (<ce:bold>5c</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.6.5</xocs:item-toc-label>
                  <xocs:item-toc-section-title>
                     <ce:italic>N</ce:italic>-<ce:italic>tert</ce:italic>-butyl-3-(5-cyano-2-(3-methyl-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)benzene-sulfonamide (<ce:bold>5d</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.7</xocs:item-toc-label>
               <xocs:item-toc-section-title>General procedure for the synthesis of compound <ce:bold>5e–g</ce:bold>
               </xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.7.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2,4-bis(3-methylanilino)pyrimidine-5-carbonitrile (<ce:bold>5e</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.7.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2,4-bis(3-methylanilino)pyrimidine-5-carboxamide (<ce:bold>5f</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.7.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[2-Methoxy-5-[3-methyl-4-(4-methylpiperazin-1-yl)1-aniline]aniline]benzenesul-fonamide (<ce:bold>5g</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.8</xocs:item-toc-label>
               <xocs:item-toc-section-title>General procedure for the synthesis of compounds <ce:bold>5h–5r</ce:bold>
               </xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-[(2-{[3-Methyl-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzamide (<ce:bold>5h</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-[(2-{[4-(4-Methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzamide (<ce:bold>5i</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-[(2-{[4-(Morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]benzamide (<ce:bold>5j</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[(2-{[3-Methyl-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide (<ce:bold>5k</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.5</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[(2-{[4-(4-methylprperazin-1-yl)phenyl]amino)pyrimidin-4-yl)amino]benzene-1-sulfonamide (<ce:bold>5l</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.6</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-[(2-{[4-(Morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide (<ce:bold>5m</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.7</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-<ce:italic>N</ce:italic>-[4-(3,4-Dimethylpiperazin-1-yl)phenyl]-4-<ce:italic>N</ce:italic>-(3-methylphenyl)pyrimidine-2,4-diamine (<ce:bold>5n</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.8</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-<ce:italic>N</ce:italic>-(3-Methylphenyl)-2-<ce:italic>N</ce:italic>-[4-(4-methylpiperazin-1-yl)phenyl]pyrimidine-2,4-diamine (<ce:bold>5o</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.9</xocs:item-toc-label>
                  <xocs:item-toc-section-title>4-<ce:italic>N</ce:italic>-(3-Methylphenyl)-2-<ce:italic>N</ce:italic>-[4-(morpholin-4-yl)phenyl]pyrimidine-2,4-diamine (<ce:bold>5p</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.10</xocs:item-toc-label>
                  <xocs:item-toc-section-title>
                     <ce:italic>N</ce:italic>,<ce:italic>N</ce:italic>′-bis(3-methylphenyl)pyrimidine-2,4-diamine (<ce:bold>5q</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.8.11</xocs:item-toc-label>
                  <xocs:item-toc-section-title>2-<ce:italic>N</ce:italic>,4-<ce:italic>N</ce:italic>-bis[4-(morpholin-4-yl)phenyl]pyrimidine-2,4-diamine (<ce:bold>5r</ce:bold>)</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.9</xocs:item-toc-label>
               <xocs:item-toc-section-title>Biological assays</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.9.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Anti-malarial activity</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.9.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Cytotoxicity</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.9.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Protein kinase activity</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-label>Appendix A</xocs:item-toc-label>
            <xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:appendices">
               <xocs:item-toc-section-title>Mol Files</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="sref1">
            <xocs:ref-normalized-surname>MILLER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>156</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref2">
            <xocs:ref-normalized-surname>WU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>853</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref3">
            <xocs:ref-normalized-surname>WHOWORLDMALARIAREPORT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
         </xocs:ref-info>
         <xocs:ref-info refid="sref4">
            <xocs:ref-normalized-surname>BIAMONTE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>2829</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref5">
            <xocs:ref-normalized-surname>SIBLEY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>373</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref6">
            <xocs:ref-normalized-surname>ASHLEY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>411</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref7">
            <xocs:ref-normalized-surname>BARNETT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>11221</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref8">
            <xocs:ref-normalized-surname>WELLS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>424</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref9">
            <xocs:ref-normalized-surname>VIAL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>396</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref10">
            <xocs:ref-normalized-surname>DERBYSHIRE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1920</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref11">
            <xocs:ref-normalized-surname>LUCET</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>2295</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>I</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref12">
            <xocs:ref-normalized-surname>LEROY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>241</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref13">
            <xocs:ref-normalized-surname>MORAHAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>23</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref14">
            <xocs:ref-normalized-surname>MBENGUE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>683</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref15">
            <xocs:ref-normalized-surname>GHIDELLIDISSE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref16">
            <xocs:ref-normalized-surname>JIRAGE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>134</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref17">
            <xocs:ref-normalized-surname>DOERIG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>279</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref18">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>456</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref19">
            <xocs:ref-normalized-surname>WARD</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>79</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref20">
            <xocs:ref-normalized-surname>CROWTHER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>e0149996</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref21">
            <xocs:ref-normalized-surname>CHAPMAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>3570</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref22">
            <xocs:ref-normalized-surname>LARGE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>6019</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref23">
            <xocs:ref-normalized-surname>WOODARD</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>3877</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref24">
            <xocs:ref-normalized-surname>BOULOC</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>5294</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref25">
            <xocs:ref-normalized-surname>KNIGHT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>130</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref26">
            <xocs:ref-normalized-surname>GAMO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>305</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref27">
            <xocs:ref-normalized-surname>DOERIG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>604</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref28">
            <xocs:ref-normalized-surname>DYMOCK</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>449</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref29">
            <xocs:ref-normalized-surname>QIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>174</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref30">
            <xocs:ref-normalized-surname>KOLLAREDDY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>2411</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref31">
            <xocs:ref-normalized-surname>LOTHARIUS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref32">
            <xocs:ref-normalized-surname>ZHOU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>1070</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref33">
            <xocs:ref-normalized-surname>SONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>238</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref34"/></xocs:ref-info>
         <xocs:ref-info refid="sref35"/></xocs:ref-info>
         <xocs:ref-info refid="sref36">
            <xocs:ref-normalized-surname>BASU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>2767</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref37">
            <xocs:ref-normalized-surname>ZUCCOTTO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>2681</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref38">
            <xocs:ref-normalized-surname>LIAO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>409</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref39">
            <xocs:ref-normalized-surname>MARTIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>698</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref40">
            <xocs:ref-normalized-surname>WOOD</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>6652</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref41">
            <xocs:ref-normalized-surname>SIU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>5014</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref42">
            <xocs:ref-normalized-surname>DESJARDINS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1979</xocs:ref-pub-year>
            <xocs:ref-first-fp>710</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref43">
            <xocs:ref-normalized-surname>TRAGER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1976</xocs:ref-pub-year>
            <xocs:ref-first-fp>673</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref44">
            <xocs:ref-normalized-surname>HUNT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>201</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref45">
            <xocs:ref-normalized-surname>MOSMANN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1983</xocs:ref-pub-year>
            <xocs:ref-first-fp>55</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref46">
            <xocs:ref-normalized-surname>KAMRAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>15</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref47">
            <xocs:ref-normalized-surname>HU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1627</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref48">
            <xocs:ref-normalized-surname>GANSTER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>8638</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref49">
            <xocs:ref-normalized-surname>LIU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1643</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref50">
            <xocs:ref-normalized-surname>ZHAO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>366</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref51">
            <xocs:ref-normalized-surname>JOHN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>2593</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref52">
            <xocs:ref-normalized-surname>DAENGROT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>615</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref53">
            <xocs:ref-normalized-surname>FORSYTH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>7653</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>PHUANGSAWAIX2016X896</xocs:refkey3>
         <xocs:refkey4lp>PHUANGSAWAIX2016X896X905</xocs:refkey4lp>
         <xocs:refkey4ai>PHUANGSAWAIX2016X896XO</xocs:refkey4ai>
         <xocs:refkey5>PHUANGSAWAIX2016X896X905XO</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="0" is-open-archive="0"/></xocs:oa-article-status>
      </xocs:open-access>
      <xocs:self-archiving>
         <xocs:sa-start-date>2018-09-24T00:00:00.000Z</xocs:sa-start-date>
         <xocs:sa-embargo-status>UnderEmbargo</xocs:sa-embargo-status>
         <xocs:sa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:sa-user-license>
      </xocs:self-archiving>
      <xocs:copyright-info>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">© 2016 Elsevier Masson SAS. All rights reserved.</xocs:cp-notice>
         </xocs:cp-notices>
      </xocs:copyright-info>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0223-5234(16)30710-3</xocs:pii-formatted>
         <xocs:pii-unformatted>S0223523416307103</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S0223523416307103</xocs:eid>
         <xocs:doi>10.1016/j.ejmech.2016.08.055</xocs:doi>
         <xocs:cid>271932</xocs:cid>
         <xocs:timestamp>2017-09-18T15:25:25.753803-04:00</xocs:timestamp>
         <xocs:cover-date-start>2016-11-29</xocs:cover-date-start>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/MAIN/application/pdf/dea5a9b143f756cb3acf55ae7d6f3782/main.pdf</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/MAIN/application/pdf/dea5a9b143f756cb3acf55ae7d6f3782/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>696497</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>10</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S0223523416307103-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/PREVIEW/image/png/5d5bd5c0f34dee70cfc59e187fb03b8b/main_1.png</xocs:ucs-locator>
                     <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/PREVIEW/image/png/5d5bd5c0f34dee70cfc59e187fb03b8b/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>54027</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-fx1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/fx1/THUMBNAIL/image/gif/0b30278f10a044be107d04de80a37644/fx1.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/fx1/THUMBNAIL/image/gif/0b30278f10a044be107d04de80a37644/fx1.sml</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>23343</xocs:filesize>
               <xocs:pixel-height>96</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-fx2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/fx2/THUMBNAIL/image/gif/484a458176a9b1d540556904b4b43e52/fx2.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/fx2/THUMBNAIL/image/gif/484a458176a9b1d540556904b4b43e52/fx2.sml</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>10711</xocs:filesize>
               <xocs:pixel-height>140</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/gr1/THUMBNAIL/image/gif/89ce845bc3a98c3938867e34c53bc3ef/gr1.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/gr1/THUMBNAIL/image/gif/89ce845bc3a98c3938867e34c53bc3ef/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>12187</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>207</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/gr2/THUMBNAIL/image/gif/6562b8905d62c3f46f05f1d9e27cb2ff/gr2.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/gr2/THUMBNAIL/image/gif/6562b8905d62c3f46f05f1d9e27cb2ff/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>22561</xocs:filesize>
               <xocs:pixel-height>94</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-sc1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/sc1/THUMBNAIL/image/gif/3fde60e9ce383862eab04f4ddf024a6b/sc1.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/sc1/THUMBNAIL/image/gif/3fde60e9ce383862eab04f4ddf024a6b/sc1.sml</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>8148</xocs:filesize>
               <xocs:pixel-height>81</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-sc2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/sc2/THUMBNAIL/image/gif/19ed0d86b66498c1c921c7d57e078363/sc2.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/sc2/THUMBNAIL/image/gif/19ed0d86b66498c1c921c7d57e078363/sc2.sml</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>7299</xocs:filesize>
               <xocs:pixel-height>47</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-fx1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/fx1/DOWNSAMPLED/image/jpeg/a3a9f139a5a2663d6e3b5fefe0079ae5/fx1.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/fx1/DOWNSAMPLED/image/jpeg/a3a9f139a5a2663d6e3b5fefe0079ae5/fx1.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>70432</xocs:filesize>
               <xocs:pixel-height>200</xocs:pixel-height>
               <xocs:pixel-width>456</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-fx2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/fx2/DOWNSAMPLED/image/jpeg/0f559598a29d328d85e8876fac1f185f/fx2.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/fx2/DOWNSAMPLED/image/jpeg/0f559598a29d328d85e8876fac1f185f/fx2.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>21201</xocs:filesize>
               <xocs:pixel-height>96</xocs:pixel-height>
               <xocs:pixel-width>150</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/gr1/DOWNSAMPLED/image/jpeg/d43a5ab11869639385586ccfd9baded4/gr1.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/gr1/DOWNSAMPLED/image/jpeg/d43a5ab11869639385586ccfd9baded4/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>54650</xocs:filesize>
               <xocs:pixel-height>405</xocs:pixel-height>
               <xocs:pixel-width>511</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/gr2/DOWNSAMPLED/image/jpeg/0fefcd02cb5a0d5c929b883ca398ecfc/gr2.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/gr2/DOWNSAMPLED/image/jpeg/0fefcd02cb5a0d5c929b883ca398ecfc/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>84363</xocs:filesize>
               <xocs:pixel-height>230</xocs:pixel-height>
               <xocs:pixel-width>535</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-sc1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/sc1/DOWNSAMPLED/image/jpeg/1dd04062d1820b3f89e5898f1dbadc39/sc1.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/sc1/DOWNSAMPLED/image/jpeg/1dd04062d1820b3f89e5898f1dbadc39/sc1.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>29845</xocs:filesize>
               <xocs:pixel-height>188</xocs:pixel-height>
               <xocs:pixel-width>512</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-sc2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/sc2/DOWNSAMPLED/image/jpeg/cbe85fda94b4c6abb8a7d1fca9da1b40/sc2.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/sc2/DOWNSAMPLED/image/jpeg/cbe85fda94b4c6abb8a7d1fca9da1b40/sc2.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>28644</xocs:filesize>
               <xocs:pixel-height>142</xocs:pixel-height>
               <xocs:pixel-width>667</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-fx1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/fx1/HIGHRES/image/jpeg/817edc552c8f2ccc2925ab56d3bf9bdf/fx1_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/fx1/HIGHRES/image/jpeg/817edc552c8f2ccc2925ab56d3bf9bdf/fx1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>387880</xocs:filesize>
               <xocs:pixel-height>886</xocs:pixel-height>
               <xocs:pixel-width>2021</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-fx2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/fx2/HIGHRES/image/jpeg/6ce9d2686693d24ed98a9909261b670b/fx2_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/fx2/HIGHRES/image/jpeg/6ce9d2686693d24ed98a9909261b670b/fx2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>45656</xocs:filesize>
               <xocs:pixel-height>425</xocs:pixel-height>
               <xocs:pixel-width>665</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/gr1/HIGHRES/image/jpeg/1236bdfd27a687e5c4658bfa39a99dd7/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/gr1/HIGHRES/image/jpeg/1236bdfd27a687e5c4658bfa39a99dd7/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>297326</xocs:filesize>
               <xocs:pixel-height>1795</xocs:pixel-height>
               <xocs:pixel-width>2264</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/gr2/HIGHRES/image/jpeg/268c503c23fc62e346decb295d5a9405/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/gr2/HIGHRES/image/jpeg/268c503c23fc62e346decb295d5a9405/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>523081</xocs:filesize>
               <xocs:pixel-height>1020</xocs:pixel-height>
               <xocs:pixel-width>2370</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-sc1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/sc1/HIGHRES/image/jpeg/48b28e0caec5cd07866d293dd552128c/sc1_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/sc1/HIGHRES/image/jpeg/48b28e0caec5cd07866d293dd552128c/sc1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>128018</xocs:filesize>
               <xocs:pixel-height>834</xocs:pixel-height>
               <xocs:pixel-width>2266</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-sc2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/sc2/HIGHRES/image/jpeg/9fb39455282e1336253717b38d6179c3/sc2_lrg.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/sc2/HIGHRES/image/jpeg/9fb39455282e1336253717b38d6179c3/sc2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc2</xocs:file-basename>
               <xocs:filename>sc2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>128420</xocs:filesize>
               <xocs:pixel-height>629</xocs:pixel-height>
               <xocs:pixel-width>2953</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-mol.zip</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/mol/MAIN/application/zip/192dfb30cecd012c2a48981289731574/mol.zip</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/mol/MAIN/application/zip/192dfb30cecd012c2a48981289731574/mol.zip</xocs:ucs-locator>
               <xocs:file-basename>mol</xocs:file-basename>
               <xocs:filename>mol.zip</xocs:filename>
               <xocs:extension>zip</xocs:extension>
               <xocs:filesize>8308</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523416307103-mmc1.docx</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523416307103/mmc1/MAIN/application/vnd.openxmlformats-officedocument.wordprocessingml.document/126b597d930c0e0b80cd6929ccae1ea0/mmc1.docx</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523416307103/mmc1/MAIN/application/vnd.openxmlformats-officedocument.wordprocessingml.document/126b597d930c0e0b80cd6929ccae1ea0/mmc1.docx</xocs:ucs-locator>
               <xocs:file-basename>mmc1</xocs:file-basename>
               <xocs:filename>mmc1.docx</xocs:filename>
               <xocs:extension>docx</xocs:extension>
               <xocs:filesize>1335081</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta><xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="fla" version="5.4" xml:lang="en">
         <item-info>
            <jid>EJMECH</jid>
            <aid>8851</aid>
            <ce:pii>S0223-5234(16)30710-3</ce:pii>
            <ce:doi>10.1016/j.ejmech.2016.08.055</ce:doi>
            <ce:copyright type="full-transfer" year="2016">Elsevier Masson SAS</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="fig1">
               <ce:label>Fig. 1</ce:label>
               <ce:caption id="cap0015">
                  <ce:simple-para id="fspara0010" view="all">2,4-Diamino-pyrimidines kinase inhibitors; TCMDC 134116 <ce:cross-ref refid="bib20" id="crosref0315">[20]</ce:cross-ref>, TG101209, <ce:cross-ref refid="bib28" id="crosref0320">[28]</ce:cross-ref> SID103904601 (<ce:inter-ref xlink:href="http://www.pubchem.com" id="intref0020" xlink:type="simple">www.pubchem.com</ce:inter-ref>) and covalent inhibitor WZ4002 <ce:cross-refs refid="bib32 bib36" id="crosrefs0075">[32,36]</ce:cross-refs>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0015">Fig. 1</ce:alt-text>
               <ce:link locator="gr1" xlink:type="simple" xlink:href="pii:S0223523416307103/gr1"/></ce:link>
            </ce:figure>
            <ce:figure id="fig2">
               <ce:label>Fig. 2</ce:label>
               <ce:caption id="cap0020">
                  <ce:simple-para id="fspara0015" view="all">Schematic (left) and docked model of 2,4-diamino-pyrimidines to PbCDPK1. The binding model of <ce:bold>5k</ce:bold> (carbons in grey) bound to the X-ray crystal structure of PbCDPK1 (3Q5I, magenta). The model was constructed using the JAK2- TG101209 complex (4JIA, cyan) <ce:cross-ref refid="bib41" id="crosref0325">[41]</ce:cross-ref>. Hydrogen bonds to the hinge and structural waters are indicated by dotted lines. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0020">Fig. 2</ce:alt-text>
               <ce:link locator="gr2" xlink:type="simple" xlink:href="pii:S0223523416307103/gr2"/></ce:link>
            </ce:figure>
            <ce:figure id="sch1">
               <ce:label>Scheme 1</ce:label>
               <ce:caption id="cap0025">
                  <ce:simple-para id="fspara0020" view="all">General scheme for the synthesis of anilines 5a-c. Reagents and conditions for <ce:bold>3a</ce:bold>: (a) K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>, DMSO, rt, 4–6 h, (b) Pd/C, H<ce:inf loc="post">2</ce:inf>, MeOH, rt, overnight.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0025">Scheme 1</ce:alt-text>
               <ce:link locator="sc1" xlink:type="simple" xlink:href="pii:S0223523416307103/sc1"/></ce:link>
            </ce:figure>
            <ce:figure id="sch2">
               <ce:label>Scheme 2</ce:label>
               <ce:caption id="cap0030">
                  <ce:simple-para id="fspara0025" view="all">Synthetic approach used for the preparation of compounds <ce:bold>1a</ce:bold>, <ce:bold>5a–r</ce:bold>. Reagents and conditions for; <ce:bold>5a</ce:bold>: (a) DIPEA, <ce:italic>n</ce:italic>-BuOH, 110 °C overnight, (b) DIPEA, DMF, rt, 4 h; <ce:bold>5i</ce:bold>, (a) DIPEA, <ce:italic>n</ce:italic>-BuOH, 110 °C overnight, (b) TFA, isopropanol, overnight.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0030">Scheme 2</ce:alt-text>
               <ce:link locator="sc2" xlink:type="simple" xlink:href="pii:S0223523416307103/sc2"/></ce:link>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl1" frame="topbot" colsep="0" rowsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption id="cap0035">
                  <ce:simple-para id="tspara0010" view="all">Representative 2,4-diamino-pyrimidine hits identified from GSK HTS data.26 Pf 3D7 (IC50, μM) and HepG2 cytotoxicity (% at 10 μM) are reported for: TCMDC-134115 (<ce:bold>1a</ce:bold>), TCMDC-134116 (<ce:bold>1b</ce:bold>), TCMDC-141384 (<ce:bold>1c</ce:bold>) and TCMDC-141383 (<ce:bold>1d</ce:bold>).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0035">Table 1</ce:alt-text>
               <ce:link locator="fx2" xlink:type="simple" xlink:href="pii:S0223523416307103/fx2"/></ce:link>
               <tgroup cols="7">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <colspec colnum="6" colname="col6"/></colspec>
                  <colspec colnum="7" colname="col7"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">ID</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">1</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">X</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3D7 IC<inf loc="post">50</inf> (μM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">HepG2 (%)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>1a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2-CONH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">NCH<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.009</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">99</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>1b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2-CONH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">NCH<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.040</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">43</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>1c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CONHCH<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3-NO<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">NCH<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.138</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">16</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>1d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CONHCH<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3-O<sup loc="post">i</sup>Pr</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">O</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.759</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">19</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl2" frame="topbot" colsep="0" rowsep="0">
               <ce:label>Table 2</ce:label>
               <ce:caption id="cap0040">
                  <ce:simple-para id="tspara0015" view="all">Sequence similarity, identity to probable Pf and host kinases.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0040">Table 2</ce:alt-text>
               <tgroup cols="5">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">ID</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">PDB ID</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">% Similarity to <italic>Pf</italic>CDPK1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">% Identity to <italic>Pf</italic>CDPK1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Gatekeeper residue</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>Pf</italic>CDPK1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Thr</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">PbCDPK1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <inter-ref xlink:href="pdb:3Q5I" id="intref0025" xlink:type="simple">3Q5I</inter-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">91.8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">87.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Thr</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">hAUR</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <inter-ref xlink:href="pdb:3UOL" id="intref0030" xlink:type="simple">3UOL</inter-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">45.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">25.3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Leu</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">hJAK2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <inter-ref xlink:href="pdb:4JI9" id="intref0035" xlink:type="simple">4JI9</inter-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">36.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">18.6</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Met</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">hEGFR</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <inter-ref xlink:href="pdb:3IKA" id="intref0040" xlink:type="simple">3IKA</inter-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">33.9</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">15.4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Met</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl3" frame="topbot" colsep="0" rowsep="0">
               <ce:label>Table 3</ce:label>
               <ce:caption id="cap0045">
                  <ce:simple-para id="tspara0020" view="all">Activities and yields of compounds <ce:bold>a1</ce:bold>, <ce:bold>5a–r</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0045">Table 3</ce:alt-text>
               <tgroup cols="10">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <colspec colnum="6" colname="col6"/></colspec>
                  <colspec colnum="7" colname="col7"/></colspec>
                  <colspec colnum="8" colname="col8"/></colspec>
                  <colspec colnum="9" colname="col9"/></colspec>
                  <colspec colnum="10" colname="col10"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">ID</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">1</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">R<inf loc="post">4</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">%yield<cross-ref refid="tbl3fna" id="crosref0335">
                              <sup loc="post">a</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">clogP<cross-ref refid="tbl3fnd" id="crosref0340">
                              <sup loc="post">d</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">MWT<cross-ref refid="tbl3fnd" id="crosref0345">
                              <sup loc="post">d</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">P.f. K1 IC<inf loc="post">50</inf> (μM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Vero cytotox (%/50 μM)</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>1a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">o-CONH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">25</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">443</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.93</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">94</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-SO<inf loc="post">2</inf>NH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">23</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">479</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5.56</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">91</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3-Me & 4-Methylpiperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">SO<inf loc="post">2</inf>NH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">15</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">479</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>NA</italic>
                           <cross-ref refid="tbl3fne" id="crosref0350">
                              <sup loc="post">e</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">33</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-SO<inf loc="post">2</inf>CH<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">26</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">478</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.72</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">92</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-SO<inf loc="post">2</inf>NH<sup loc="post">t</sup>Bu</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">39</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5.4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">535</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.56</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">31</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5e</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CN</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">50<cross-ref refid="tbl3fnb" id="crosref0380">
                              <sup loc="post">b</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">315</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>NA</italic>
                           <cross-ref refid="tbl3fne" id="crosref0355">
                              <sup loc="post">e</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">40</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5f</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">CONH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">48<cross-ref refid="tbl3fnc" id="crosref0385">
                              <sup loc="post">c</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">333</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>NA</italic>
                           <cross-ref refid="tbl3fne" id="crosref0360">
                              <sup loc="post">e</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">96</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5g</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">OMe</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-SO<inf loc="post">2</inf>NH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">91</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">484</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5.26</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">88</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5h</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">o-CONH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">67</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">418</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1.06</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">92</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5i</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">o-CONH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">56</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">403</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1.50</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">91</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5j</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">o-CONH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">morpholine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">11</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">390</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.39</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">68</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-SO<inf loc="post">2</inf>NH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">70</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">454</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.86</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">66</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5l</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-SO<inf loc="post">2</inf>NH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">62</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2.8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">440</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">7.25</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">80</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5m</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-SO<inf loc="post">2</inf>NH<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">morpholine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">75</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2.7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">427</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">8.97</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">35</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5n</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">80</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">389</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.647</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">94</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5o</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me-piperazine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">82</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.7</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">374</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.431</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">94</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5p</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">morpholine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">79</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.6</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">361</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>NA</italic>
                           <cross-ref refid="tbl3fne" id="crosref0365">
                              <sup loc="post">e</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">74</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5q</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>m</italic>-Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Me</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1.5</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">5.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">290</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>NA</italic>
                           <cross-ref refid="tbl3fne" id="crosref0370">
                              <sup loc="post">e</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">94</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5r</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4-phenylmorpholine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">morpholine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">20</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">433</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <italic>NA</italic>
                           <cross-ref refid="tbl3fne" id="crosref0375">
                              <sup loc="post">e</sup>
                           </cross-ref>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">25</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col5">Chloroquine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.9</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">320</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.57</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">45</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col5">Mefloquine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">378</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.07</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">–</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col1" nameend="col5">Dihydroartemisinine</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">–</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2.8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">284</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.00254</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">–</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:table-footnote id="tbl3fna">
                  <ce:label>a</ce:label>
                  <ce:note-para id="tspara0030a" view="all">%yield obtained from di-substitution reaction at 2- and 4- position using condition.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl3fnb">
                  <ce:label>b</ce:label>
                  <ce:note-para id="tspara0030g" view="all">obtained as a by-product of the reaction to produce intermediate <ce:bold>5e</ce:bold>.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl3fnc">
                  <ce:label>c</ce:label>
                  <ce:note-para id="tspara0030h" view="all">%yield obtained from oxidation reaction of compound <ce:bold>7</ce:bold>.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl3fnd">
                  <ce:label>d</ce:label>
                  <ce:note-para id="tspara0030t" view="all">Calculated logarithm of the octanol/water distribution coefficient using JChem Version 14.9.100.707.</ce:note-para>
               </ce:table-footnote>
               <ce:table-footnote id="tbl3fne">
                  <ce:label>e</ce:label>
                  <ce:note-para id="tspara0030r" view="all">Compound not active.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl4" frame="topbot" colsep="0" rowsep="0">
               <ce:label>Table 4</ce:label>
               <ce:caption id="cap0050">
                  <ce:simple-para id="tspara0045" view="all">Activity of compounds selected for kinase selectivity and further cytotoxicity assessment.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0050">Table 4</ce:alt-text>
               <tgroup cols="6">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <colspec colnum="6" colname="col6"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1">ID</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col2" nameend="col4">IC<inf loc="post">50</inf>, μM</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col5" nameend="col6">EC<inf loc="post">50</inf>, μM</entry>
                     </row>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">JAK3</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">EGFR</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Vero</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">A549</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">>100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">>100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">>150</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">45.4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">>100</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.126</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">>150</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">>100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">4.2</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5m</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.129</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">7.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">>100</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">37.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">9.4</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5n</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.05</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1.8</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">>150</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">3.5</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">
                           <bold>5o</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">0.14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">2.1</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">11.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">1.0</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">7.1</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
         </ce:floats>
         <head>
            <ce:dochead id="dhead0010">
               <ce:textfn>Research paper</ce:textfn>
            </ce:dochead>
            <ce:title id="title0010">Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors</ce:title>
            <ce:author-group id="augrp0010">
               <ce:author id="au1" author-id="S0223523416307103-aeca4cc04f649b6c0748debf4c4244e2">
                  <ce:given-name>Oraphan</ce:given-name>
                  <ce:surname>Phuangsawai</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0010">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au2" author-id="S0223523416307103-3da2696666a53d24012fa378c456c2ee">
                  <ce:given-name>Paul</ce:given-name>
                  <ce:surname>Beswick</ce:surname>
                  <ce:cross-ref refid="aff2" id="crosref0015">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au3" author-id="S0223523416307103-896f1801de1a855c851def22518053d4">
                  <ce:given-name>Siriluk</ce:given-name>
                  <ce:surname>Ratanabunyong</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0020">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au4" author-id="S0223523416307103-a5734f608f39745c3a80dfddf4601061">
                  <ce:given-name>Lueacha</ce:given-name>
                  <ce:surname>Tabtimmai</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0025">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au5" author-id="S0223523416307103-e51956ff2547cb3b8a9fed7728bc27e4">
                  <ce:given-name>Praphasri</ce:given-name>
                  <ce:surname>Suphakun</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0030">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au6" author-id="S0223523416307103-a0f00e1a4f0de4b3b4763397a2b9b802">
                  <ce:given-name>Phongphat</ce:given-name>
                  <ce:surname>Obounchoey</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0035">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="aff4" id="crosref0330">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au7" author-id="S0223523416307103-fc7054f32286d8fc64efc77b1e1a48a1">
                  <ce:given-name>Pimonwan</ce:given-name>
                  <ce:surname>Srisook</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0040">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au8" author-id="S0223523416307103-49235ba08961c4d4911a2644b27a73f2">
                  <ce:given-name>Natharinee</ce:given-name>
                  <ce:surname>Horata</ce:surname>
                  <ce:cross-ref refid="aff5" id="crosref0045">
                     <ce:sup loc="post">e</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au9" author-id="S0223523416307103-00a72bb8312f38d0350606c5a392daaf">
                  <ce:given-name>Irina</ce:given-name>
                  <ce:surname>Chuckowree</ce:surname>
                  <ce:cross-ref refid="aff2" id="crosref0050">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au10" author-id="S0223523416307103-11ba94d542c2ee875886adc7b5ea0520">
                  <ce:given-name>Supa</ce:given-name>
                  <ce:surname>Hannongbua</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0055">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au11" author-id="S0223523416307103-279dd5b9b240cd93aad5daeb4fee531e">
                  <ce:given-name>Simon E.</ce:given-name>
                  <ce:surname>Ward</ce:surname>
                  <ce:cross-ref refid="aff2" id="crosref0060">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cor2" id="crosref0065">
                     <ce:sup loc="post">∗∗</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au12" author-id="S0223523416307103-0746cb64387840b1bff96c8e35aca87d">
                  <ce:given-name>Kiattawee</ce:given-name>
                  <ce:surname>Choowongkomon</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0070">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au13" author-id="S0223523416307103-152aa6bf307c9dce1cc662c84e78f69c">
                  <ce:given-name>M. Paul</ce:given-name>
                  <ce:surname>Gleeson</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0075">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cor1" id="crosref0080">
                     <ce:sup loc="post">∗</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:affiliation id="aff1">
                  <ce:label>a</ce:label>
                  <ce:textfn>Department of Chemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Department of Chemistry</sa:organization>
                     <sa:organization>Faculty of Science</sa:organization>
                     <sa:organization>Kasetsart University</sa:organization>
                     <sa:city>Bangkok</sa:city>
                     <sa:postal-code>10900</sa:postal-code>
                     <sa:country>Thailand</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff2">
                  <ce:label>b</ce:label>
                  <ce:textfn>School of Life Sciences, University of Sussex, Brighton BN1 9QJ, United Kingdom</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>School of Life Sciences</sa:organization>
                     <sa:organization>University of Sussex</sa:organization>
                     <sa:city>Brighton</sa:city>
                     <sa:postal-code>BN1 9QJ</sa:postal-code>
                     <sa:country>United Kingdom</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff3">
                  <ce:label>c</ce:label>
                  <ce:textfn>Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Department of Biochemistry</sa:organization>
                     <sa:organization>Faculty of Science</sa:organization>
                     <sa:organization>Kasetsart University</sa:organization>
                     <sa:city>Bangkok</sa:city>
                     <sa:postal-code>10900</sa:postal-code>
                     <sa:country>Thailand</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff4">
                  <ce:label>d</ce:label>
                  <ce:textfn>Interdisciplinary Program in Genetic Engineering, Graduate School, Kasetsart University, Chatuchak, Bangkok 10900, Thailand</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Interdisciplinary Program in Genetic Engineering, Graduate School, Kasetsart University</sa:organization>
                     <sa:city>Chatuchak</sa:city>
                     <sa:state>Bangkok</sa:state>
                     <sa:postal-code>10900</sa:postal-code>
                     <sa:country>Thailand</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff5">
                  <ce:label>e</ce:label>
                  <ce:textfn>Faculty of Medicinal Technology, Huachiew Chalermprakiet University, Samut Prakarn 10540, Thailand</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Faculty of Medicinal Technology</sa:organization>
                     <sa:organization>Huachiew Chalermprakiet University</sa:organization>
                     <sa:state>Samut Prakarn</sa:state>
                     <sa:postal-code>10540</sa:postal-code>
                     <sa:country>Thailand</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>∗</ce:label>
                  <ce:text>Corresponding author.</ce:text>
               </ce:correspondence>
               <ce:correspondence id="cor2">
                  <ce:label>∗∗</ce:label>
                  <ce:text>Corresponding author.</ce:text>
               </ce:correspondence>
            </ce:author-group>
            <ce:date-received day="18" month="6" year="2016"/></ce:date-received>
            <ce:date-revised day="23" month="8" year="2016"/></ce:date-revised>
            <ce:date-accepted day="24" month="8" year="2016"/></ce:date-accepted>
            <ce:abstract xml:lang="en" id="abs0010" view="all" class="author"><ce:abstract-sec id="abssec0010" view="all">
                  <ce:simple-para id="abspara0010" view="all">A series of 2,4 diamino-pyrimidines have been identified from an analysis of open access high throughput anti-malarial screening data reported by GlaxoSmithKline at the 3D7 and resistant Dd2 strains. SAR expansion has been performed using structural knowledge of the most plausible parasite target. Seventeen new analogs have been synthesized and tested against the resistant K1 strain of <ce:italic>Plasmodium falciparum</ce:italic> (<ce:italic>Pf</ce:italic>). The cytotoxicity of the compounds was assessed in Vero and A549 cells and their selectivity towards human kinases including JAK2 and EGFR were undertaken. We identified compound <ce:bold>5n</ce:bold> and <ce:bold>5m</ce:bold> as sub-micromolar inhibitors, with equivalent anti-malarial activity to Chloroquine (CQ). Compounds <ce:bold>5d</ce:bold> and <ce:bold>5k</ce:bold>, μM inhibitors of <ce:italic>Pf</ce:italic>, displayed improved cytotoxicity with weak inhibition of the human kinases.</ce:simple-para>
               </ce:abstract-sec></ce:abstract>
            <ce:abstract class="graphical" id="abs0015" view="all">
               <ce:section-title id="sectitle0015">Graphical abstract</ce:section-title>
               <ce:abstract-sec id="abssec0015" view="all">
                  <ce:simple-para id="abspara0015" view="all">
                     <ce:display>
                        <ce:figure id="undfig1">
                           <ce:alt-text role="short" id="alttext0010">Image 1</ce:alt-text>
                           <ce:link locator="fx1" xlink:type="simple" xlink:href="pii:S0223523416307103/fx1"/></ce:link>
                        </ce:figure>
                     </ce:display>
                  </ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            
            <ce:keywords xml:lang="en" id="kwrds0010" view="all" class="keyword">
               <ce:section-title id="sectitle0025">Keywords</ce:section-title>
               <ce:keyword id="kwrd0010">
                  <ce:text>2,4-Diaminopyrimidine</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0015">
                  <ce:text>Plasmodium falciparum</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0020">
                  <ce:text>Antimalarials</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0025">
                  <ce:text>Drug design</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0030">
                  <ce:text>Tyrosine kinase inhibitors</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0035">
                  <ce:text>K1 strain</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0040">
                  <ce:text>JAK2 kinase</ce:text>
               </ce:keyword>
            </ce:keywords>
            <ce:keywords class="inchikey" id="kwrds0015" view="all">
               <ce:section-title id="sectitle0030">InChIKey</ce:section-title>
               <ce:keyword id="kwrd0045">
                  <ce:text>DCCVVSLWVBTRLY-UHFFFAOYSA-N</ce:text>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="sec1" role="introduction" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="sectitle0035">Introduction</ce:section-title>
                  <ce:para id="p0030" view="all">Malaria is tropical infectious disease of humans and other animals caused by mosquito-borne parasites that include <ce:italic>Plasmodium falciparum</ce:italic> (<ce:italic>Pf</ce:italic>) and <ce:italic>Plasmodium vivax</ce:italic> (<ce:italic>Pv</ce:italic>). The former causes the greatest percentage of deaths due to its more severe symptoms. The disease is prevalent in tropical climates in the African and Asian sub-continents, affecting countries with less developed economies <ce:cross-refs refid="bib1 bib2" id="crosrefs0010">[1,2]</ce:cross-refs>. In 2015 the World Health Organization (WHO) reported that approximately 5.9 million of children under five years of age died from this infectious disease <ce:cross-ref refid="bib3" id="crosref0085">[3]</ce:cross-ref>. To reduce the ongoing issue of drug resistance, the current frontline treatment artemisinin is given as a combination only, yet there are signs that its efficacy is under threat <ce:cross-refs refid="bib4 bib5 bib6" id="crosrefs0015">[4–6]</ce:cross-refs>. New antimalarial drugs that target novel modes of action are therefore highly desirable to tackle this disease <ce:cross-refs refid="bib7 bib8 bib9 bib10 bib11" id="crosrefs0020">[7–11]</ce:cross-refs>.</ce:para>
                  <ce:para id="p0035" view="all">The malaria parasite has a complex life cycle in which multiple kinase enzymes play an important role <ce:cross-refs refid="bib12 bib13" id="crosrefs0025">[12,13]</ce:cross-refs>. The target of the artemisinin has recently been suggested to be phosphoinositide 3-kinase (<ce:italic>Pf</ce:italic>PI3K) <ce:cross-ref refid="bib14" id="crosref0090">[14]</ce:cross-ref>, while the target of the MMV development compound MMV390048 was proposed to be phosphoinositide 4-kinase (<ce:italic>Pf</ce:italic>PI4K) <ce:cross-ref refid="bib15" id="crosref0095">[15]</ce:cross-ref>. Additional protein kinases have also been implicated as possible targets <ce:cross-refs refid="bib16 bib17 bib18" id="crosrefs0030">[16–18]</ce:cross-refs>. A number of studies aimed at improving our understanding of the approximately 65 <ce:italic>Pf</ce:italic> specific kinases have been reported, many of which share considerable homology with human kinases <ce:cross-refs refid="bib10 bib16 bib19" id="crosrefs0035">[10,16,19]</ce:cross-refs>. This has led to a kinase screening campaign <ce:cross-ref refid="bib20" id="crosref0100">[20]</ce:cross-ref> and SAR studies on specific protein kinases, including <ce:italic>Pf</ce:italic>CDPK1 <ce:cross-refs refid="bib21 bib22" id="crosrefs0040">[21,22]</ce:cross-refs>, <ce:italic>Pf</ce:italic>PK5 <ce:cross-ref refid="bib23" id="crosref0105">[23]</ce:cross-ref> and <ce:italic>Pf</ce:italic>PK7 <ce:cross-ref refid="bib24" id="crosref0110">[24]</ce:cross-ref>. Nevertheless, it is not yet established which parasite kinase represents the most valid target <ce:cross-ref refid="bib10" id="crosref0115">[10]</ce:cross-ref>, or whether polypharmacology approaches could represent a useful approach, as found for cancer <ce:cross-ref refid="bib25" id="crosref0120">[25]</ce:cross-ref>.</ce:para>
                  <ce:para id="p0040" view="all">In 2010, GlaxoSmithKline reported the results of screening of almost 2 million compounds to identify anti-malarial hits. Approximately 13,500 compounds with activity at <ce:italic>P. falciparum</ce:italic> (<ce:italic>Pf</ce:italic>) 3D7, multi-drug resistant Dd2 <ce:italic>Pf</ce:italic> strain and for cytotoxicity in the HepG2 cell line were released in the public domain <ce:cross-ref refid="bib26" id="crosref0125">[26]</ce:cross-ref>. In 2016, these hits were re-assessed at five <ce:italic>Pf</ce:italic> kinases (<ce:italic>Pf</ce:italic>CDPK1, <ce:italic>Pf</ce:italic>CDPK4, <ce:italic>Pf</ce:italic>PK6, <ce:italic>Pf</ce:italic>PK7 and <ce:italic>Pf</ce:italic>MAPK2) and led to the identification of twelve series with potential for optimization <ce:cross-ref refid="bib20" id="crosref0130">[20]</ce:cross-ref>.</ce:para>
                  <ce:para id="p0045" view="all">Our separate analysis of the GSK screening data led to the identification of a cluster of 2,4-diaminopyrimidine compounds with good activity, efficiency, physical properties and synthetic tractability (<ce:cross-ref refid="tbl1" id="crosref0135">Table 1</ce:cross-ref>
                     <ce:float-anchor refid="tbl1"/></ce:float-anchor>). The compounds display activity at the multidrug resistant Dd2 strain, whilst the HepG2 SAR suggests an anti-malarial vs. cytotoxicity window of 50 fold is achievable (<ce:cross-ref refid="tbl1" id="crosref0140">Table 1</ce:cross-ref>). <ce:bold>1b</ce:bold> is a confirmed inhibitor of <ce:italic>Pf</ce:italic>CDPK1 (0.012 μM), CDPK4 (0.089 μM) and <ce:italic>Pf</ce:italic>PK6 (0.054 μM). Host kinase interactions also require consideration as these could either lead to cytotoxicity or also potentially facilitate parasite eradication <ce:cross-refs refid="bib17 bib27" id="crosrefs0045">[17,27]</ce:cross-refs>.</ce:para>
                  <ce:para id="p0050" view="all">The most probable human kinases targeted by <ce:bold>1a–d</ce:bold> include Janus kinase 2 (hJAK2) <ce:cross-ref refid="bib28" id="crosref0145">[28]</ce:cross-ref> and Aurora A hAURKA <ce:cross-refs refid="bib29 bib30" id="crosrefs0050">[29,30]</ce:cross-refs>. Indeed, other hJAK and hAUR inhibitor classes have shown anti-malarial activity from repurposing studies <ce:cross-refs refid="bib10 bib31" id="crosrefs0055">[10,31]</ce:cross-refs>. The 2,4-diaminopyrimidine chemotype also appears in Epidermal growth factor (hEGFR) <ce:cross-ref refid="bib32" id="crosref0150">[32]</ce:cross-ref>, and c-Jun <ce:italic>N</ce:italic>-terminal kinase (hJNK) <ce:cross-ref refid="bib33" id="crosref0155">[33]</ce:cross-ref> publications, as well as in patents targeting cancer-related pathways via hJAK <ce:cross-ref refid="bib34" id="crosref0160">[34]</ce:cross-ref> and hAURK (<ce:cross-ref refid="fig1" id="crosref0165">Fig. 1</ce:cross-ref>
                     <ce:float-anchor refid="fig1"/></ce:float-anchor>) <ce:cross-ref refid="bib35" id="crosref0170">[35]</ce:cross-ref>. Kinase inhibitors offer great potential as anti-malarials due to the wealth of chemical, biological and safety data amassed over many years to treat diseases in humans, potentially reducing the development burden.</ce:para>
                  <ce:para id="p0055" view="all">In this study we report the design, synthesis and biological evaluation of new 2,4-diaminopyrimidine compounds. Our goal is to improve our SAR understanding of this series by screening additional analogs at the drug-resistant K1 <ce:italic>Pf</ce:italic> strain in the belief that molecules which target either individual, or a defined subset of kinases, offer potential new approaches to kill resistant strains. We also assess the cytotoxicity of the series using monkey kidney epithelial cell line (Vero), and the adenocarcinomic human alveolar basal epithelial cell line (A549). The human kinase activity of a subset are also evaluated for their potential to inhibit the human protein kinases: JAK2, JAK3 and EGFR.</ce:para>
               </ce:section>
               <ce:section id="sec2" role="results" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="sectitle0040">Results</ce:section-title>
                  <ce:section id="sec2.1" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="sectitle0045">Design</ce:section-title>
                     <ce:para id="p0060" view="all">The mode of action of compounds 1<ce:bold>a–d</ce:bold> is unconfirmed, however <ce:italic>Pf</ce:italic>CDPK1, hAUR, hJAK and EGFR are probable targets. A focused library of 2,4-diamino-pyrimidines derivatives were prepared using established synthetic methods and directed towards improving our understanding the link between <ce:italic>Pf</ce:italic> activity, cytotoxicity and activity at key kinases in the hosts.</ce:para>
                     <ce:para id="p0065" view="all">Crystal structures of the Plasmodium Berghei (Pb) CDPK1 homolog and the principal human targets were downloaded for analysis (<ce:cross-ref refid="tbl2" id="crosref0175">Table 2</ce:cross-ref>
                        <ce:float-anchor refid="tbl2"/></ce:float-anchor>). Despite dramatic differences in sequence identity, the conserved ATP binding site means inhibitors can have considerably cross reactivity <ce:cross-ref refid="bib10" id="crosref0180">[10]</ce:cross-ref>. A key difference between these targets is the moderately sized, non-polar gatekeeper for the human proteins, compared to the smaller, more polar Thr sidechain <ce:cross-ref refid="bib37" id="crosref0185">[37]</ce:cross-ref>.</ce:para>
                     <ce:para id="p0070" view="all">We have undertaken modification to the chemotype at four different positions as highlighted in <ce:cross-ref refid="fig2" id="crosref0190">Fig. 2</ce:cross-ref>
                        <ce:float-anchor refid="fig2"/></ce:float-anchor>. Region 1 exploits the difference at the gatekeeper while region 2 (pyrimidine 4 position) targets differences within the kinase backpocket <ce:cross-ref refid="bib38" id="crosref0195">[38]</ce:cross-ref>. Modifications at the latter position have resulted in dramatic changes in the hAURA protein conformation though the flipping of the DFG-loop despite only subtle changes in substitution of the 4-position aniline <ce:cross-ref refid="bib39" id="crosref0200">[39]</ce:cross-ref>. Modifications at region 3 will induce subtle changes in ring conformation, which can benefit selectivity, while region 4 can be exploited to improve compound solubility <ce:cross-ref refid="bib40" id="crosref0205">[40]</ce:cross-ref>. Anti-malarial SAR shows that compounds with R1 = -CN have higher anti-malarial activity, however, this is mirrored by increases in the % cytotoxicity. We therefore evaluated the effect of incorporation of -H, -CN, -OMe and -CONH<ce:inf loc="post">2</ce:inf>. A range of substituted anilines at the 2- and 4- positions were selected to exploit interaction toward the kinase solvent pocket and backpocket, respectively, and maintain reasonable molecule properties (<ce:cross-ref refid="tbl3" id="crosref0210">Table 3</ce:cross-ref>
                        <ce:float-anchor refid="tbl3"/></ce:float-anchor>). We attempted to bias the reagent selection to focus on lower MWT (mean = 405 da) and clogP (mean = 4.04). This was with the goal of increasing the likelihood of achieving better solubility and permeability and solubility, a pre-requisite for reliable phenotypic testing.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.2" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="sectitle0050">Synthesis</ce:section-title>
                     <ce:para id="p0075" view="all">Intermediates were synthesized using the methodology described in <ce:cross-ref refid="sch1" id="crosref0215">Scheme 1</ce:cross-ref>
                        <ce:float-anchor refid="sch1"/></ce:float-anchor>. <ce:bold>2a</ce:bold> was produced from the reaction of <ce:italic>p</ce:italic>-fluoronitrobenzene and piperazine in DMSO with the assistance of K<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>. The amine product was hydrogenated to <ce:bold>3a</ce:bold> using Pd/C and H<ce:inf loc="post">2</ce:inf>. Intermediates <ce:bold>3b</ce:bold> & <ce:bold>3c</ce:bold> were produced in the same manner.</ce:para>
                     <ce:para id="p0080" view="all">Compound <ce:bold>1a</ce:bold> was synthesized following <ce:cross-ref refid="sch2" id="crosref0220">Scheme 2</ce:cross-ref>
                        <ce:float-anchor refid="sch2"/></ce:float-anchor>. The Cl at the 4-position of 5-cyano-2,4-dichloropyrimidine was substituted by <ce:italic>p</ce:italic>-aminobenzamide with the assistance of DIPEA giving intermediate <ce:bold>4a</ce:bold> (<ce:cross-ref refid="sch2" id="crosref0225">Scheme 2</ce:cross-ref>). Intermediate <ce:bold>4a</ce:bold> was reacted at with <ce:bold>3a</ce:bold> assisted of DIPEA, leading to substitution at the 2-position. Compounds 5<ce:bold>a–e</ce:bold> were synthesized in an analogous manner to <ce:bold>1a.</ce:bold> Compound <ce:bold>5e</ce:bold> was oxidized using hydrogen peroxide to yield compound <ce:bold>5f</ce:bold>. Compound <ce:bold>5g</ce:bold>, having an -OMe substituent at the 5-position was synthesized using the same protocol as <ce:bold>1a</ce:bold> 
                        <ce:cross-ref refid="bib35" id="crosref0230">[35]</ce:cross-ref>. Compounds 5<ce:bold>h–r</ce:bold>, with H at the 5-position, were synthesized as follows; nucleophilic substitution at the 4-position of 2,4-dichloro pyrimidine was achieved using DIPEA base for R<ce:inf loc="post">2</ce:inf> = 3-SO<ce:inf loc="post">2</ce:inf>NH<ce:inf loc="post">2</ce:inf> and 3-CH<ce:inf loc="post">3</ce:inf>, a HCl promoted reaction for R<ce:inf loc="post">2</ce:inf> = 2-CONH<ce:inf loc="post">2</ce:inf>. Nucleophilic attack at the corresponding 2-position was achieved using TFA to promote the reaction.</ce:para>
                     <ce:para id="p0085" view="all">Nineteen compounds were synthesized (<ce:cross-ref refid="tbl3" id="crosref0235">Table 3</ce:cross-ref>) with reaction yields varied from low (<30%) to excellent (>90%). Among the 19 compounds synthesized, compounds <ce:bold>1a</ce:bold> and <ce:bold>5j</ce:bold>. <ce:bold>1a</ce:bold> was originally reported in the study of Gamo et al. <ce:cross-ref refid="bib26" id="crosref0240">[26]</ce:cross-ref> and in the recent paper of Crothers et al. <ce:cross-ref refid="bib20" id="crosref0245">[20]</ce:cross-ref> 
                        <ce:bold>5j</ce:bold> was reported as a JNK2 inhibitor by Song et al. targeted towards anti-cancer therapies <ce:cross-ref refid="bib33" id="crosref0250">[33]</ce:cross-ref>.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.3" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="sectitle0055">Biological testing</ce:section-title>
                     <ce:section id="sec2.3.1" view="all">
                        <ce:label>2.3.1</ce:label>
                        <ce:section-title id="sectitle0060">Anti-malarial activity</ce:section-title>
                        <ce:para id="p0090" view="all">The titled compounds <ce:bold>1a</ce:bold>, <ce:bold>5a–r</ce:bold> were evaluated for their <ce:italic>in vitro</ce:italic> anti-malarial activity at the <ce:italic>Pf</ce:italic> K1 strain (EC<ce:inf loc="post">50</ce:inf>) using a hypoxanthine incorporation assay <ce:cross-refs refid="bib42 bib43" id="crosrefs0060">[42,43]</ce:cross-refs>. The compounds show a range in potency from 0.43 to 8.97 μM. Compound <ce:bold>1a</ce:bold>, 0.009 μM against the 3D7 strain, was found to be 3.9 μM at the resistant K1 strain. Compounds <ce:bold>5n</ce:bold> and <ce:bold>5o</ce:bold> were 0.65 and 0.43 μM respectively. In comparison, standards chloroquine displayed an activity 0.57 μM, Mefloquine 0.07 μM and artemisinin at 0.002 μM.</ce:para>
                        <ce:para id="p0095" view="all">Systematic analysis of the results presented in <ce:cross-ref refid="tbl3" id="crosref0255">Table 3</ce:cross-ref> suggests that compounds with –H at R1 are preferred for anti-malarial activity (as exemplified by <ce:bold>5a,r</ce:bold>). R2 position shows a preference for anilines with R2 = 3-Me (<ce:bold>5a,r</ce:bold>) or 2-CONH<ce:inf loc="post">2</ce:inf> (<ce:bold>5k,m</ce:bold>). The R<ce:inf loc="post">3</ce:inf> position does not display a clear preference towards the substituents employed. R4 shows a general preference towards Me-piperazine, compared to morpholine or the simpler substituted anilines.</ce:para>
                     </ce:section>
                     <ce:section id="sec2.3.2" view="all">
                        <ce:label>2.3.2</ce:label>
                        <ce:section-title id="sectitle0065">Cytotoxicity</ce:section-title>
                        <ce:para id="p0100" view="all">Compounds <ce:bold>1a</ce:bold>, <ce:bold>5a–r</ce:bold> were evaluated for their cytotoxicity at 10 μM against the Vero cell line (ATCC CCL-81) using the method described by Hunt and co-workers <ce:cross-ref refid="bib44" id="crosref0260">[44]</ce:cross-ref>. The compounds show a range in potency from 25 to 96%. A degree of correlation between activity and cytotoxicity, with the most potent compounds (<ce:bold>5n,o</ce:bold>) also displaying high (94%) cytotoxicity. This compares to 50% for chloroquine, a standard anti-malarial treatment. Compounds <ce:bold>5d, 5k</ce:bold> and <ce:bold>5m</ce:bold> display μM anti-malarial activity and low to moderate cytotoxicity at 31, 66 and 35%, respectively.</ce:para>
                        <ce:para id="p0105" view="all">Five compounds were taken forward for further assessment; potent but cytotoxic compounds (<ce:bold>5n,o</ce:bold>), moderately potent and cytotoxic compounds (<ce:bold>5k</ce:bold>), and moderately potent and weakly cytotoxic compounds (<ce:bold>5d,m</ce:bold>). EC<ce:inf loc="post">50</ce:inf>s against the Vero (ATCC CCL-81) and A549 (ATCC CCL-185) cells using an MTT based method (<ce:cross-ref refid="tbl4" id="crosref0265">Table 4</ce:cross-ref>
                           <ce:float-anchor refid="tbl4"/></ce:float-anchor>) <ce:cross-ref refid="bib45" id="crosref0270">[45]</ce:cross-ref>. The EC<ce:inf loc="post">50</ce:inf>s are in good agreement with the % cytotoxicity data, with <ce:bold>5d,k</ce:bold> & <ce:bold>m</ce:bold> demonstrating better activity than compounds <ce:bold>5n,o</ce:bold>. The A549 cytotoxicity data broadly mirrors those obtained in the Vero cell line. The lower EC<ce:inf loc="post">50</ce:inf> values would be consistent with the higher expression of certain kinases in this disease tissue <ce:cross-refs refid="bib46 bib47 bib48 bib49 bib50" id="crosrefs0065">[46–50]</ce:cross-refs>.</ce:para>
                        <ce:para id="p0110" view="all">No clear SAR is apparent at the R1 and R2 positions. Hydrogen is preferred at the R<ce:inf loc="post">3</ce:inf> position and -H and morpholine are preferred at the R4 position. Compounds <ce:bold>5k</ce:bold> and <ce:bold>5m</ce:bold> show a reasonable balance of anti-malarial activity and cytotoxicity, approaching the desired 50-fold window.</ce:para>
                     </ce:section>
                     <ce:section id="sec2.3.3" view="all">
                        <ce:label>2.3.3</ce:label>
                        <ce:section-title id="sectitle0070">Protein kinase activity</ce:section-title>
                        <ce:para id="p0115" view="all">Compounds <ce:bold>1a, 5a–r</ce:bold> were evaluated for their <ce:italic>in vitro</ce:italic> inhibition of human kinases JAK2, JAK3 and EGFR (<ce:cross-ref refid="tbl4" id="crosref0275">Table 4</ce:cross-ref>). Inhibition was determined by using an Antibody Beacon™ Tyrosine Kinase Assay Kit (A-35725; Invitrogen, USA). Compounds <ce:bold>5k,m–o</ce:bold> display sub μM inhibition at hJAK2 kinase, μM inhibition at hJAK3 and all compounds display >10 μM inhibition at hEGFR.</ce:para>
                        <ce:para id="p0120" view="all">Compounds <ce:bold>5m</ce:bold> and <ce:bold>5o</ce:bold>, the most potent anti-malarials, but also the most cytotoxic of compounds are more active at the human kinases assessed. <ce:bold>5o</ce:bold> is a confirmed inhibitor of all three protein kinases while compound <ce:bold>5n</ce:bold> inhibits JAK2 at 0.05 μM. In contrast, <ce:bold>5d</ce:bold> shows minimal inhibition of the kinases and also displays good cytotoxicity at both the Vero and A549 cell lines.</ce:para>
                        <ce:para id="p0125" view="all">Inhibiting multiple <ce:italic>Pf</ce:italic> kinase targets without harming human cells will be a challenge, particularly since many kinase compounds come from human anti-cancer projects <ce:cross-ref refid="bib20" id="crosref0280">[20]</ce:cross-ref>. Yet, there is considerable safety and tolerability information in relation to kinase inhibition profiles that could be leveraged to develop molecules with a more targeted pharmacology. Furthermore, tackling host-parasite target interactions is also a feature of established DHFR anti-malarials. Methotrexate, a hDHFR inhibitor used in cancer treatment, also has potential as a <ce:italic>Pf</ce:italic>DHFR anti-malarial if used at lower doses <ce:cross-ref refid="bib51" id="crosref0285">[51]</ce:cross-ref>.</ce:para>
                     </ce:section>
                  </ce:section>
               </ce:section>
               <ce:section id="sec3" role="conclusion" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="sectitle0075">Conclusions</ce:section-title>
                  <ce:para id="p0130" view="all">We identified a series of diamino-pyrimidines anti-malarial from mining the screening data reported by GSK <ce:cross-ref refid="bib26" id="crosref0290">[26]</ce:cross-ref>. We performed the design, synthesis and testing of new analogs to reveal additional SAR with respect to the K1 strain, cytotoxicity at the Vero and A549 cell lines as well as inhibition at representative human kinases.</ce:para>
                  <ce:para id="p0135" view="all">Sixteen new compounds have been synthesized and evaluated against the K1 resistant <ce:italic>Pf</ce:italic> strain. The compounds displayed activity comparable to chloroquine. We identified <ce:bold>5n</ce:bold> and <ce:bold>5o</ce:bold> as having sub μM anti-malarial activity. These compounds were also identified as being potent human kinase inhibitors as well as being cytotoxic. Compounds <ce:bold>5d</ce:bold> and <ce:bold>5k</ce:bold> were identified as μM inhibitors with improved cytotoxicity and human kinase selectivity.</ce:para>
                  <ce:para id="p0140" view="all">Results suggest series has potential but further work needed to explore the strain dependence and maximize the anti-malarial/potency window. Additional work is required to establish the molecular target(s) of this compound class.</ce:para>
               </ce:section>
               <ce:section id="sec4" role="materials-methods" view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title id="sectitle0080">Experimental details</ce:section-title>
                  <ce:section id="sec4.1" view="all">
                     <ce:label>4.1</ce:label>
                     <ce:section-title id="sectitle0085">Chemistry</ce:section-title>
                     <ce:para id="p0145" view="all">Reagents and solvents obtained from commercial suppliers were used without further purification. All reactions were monitored by TLC aluminum/silica gel plate with UV light visualization. Column chromatography was performed using silica gel 60 (40–63 μm). <ce:sup loc="pre">1</ce:sup>H NMR spectra were recorded on both Varian instrument at 400 MHz and on a Bruker instrument at 500 MHz. Chemical shifts were reported in ppm (<ce:italic>δ</ce:italic>) using the residual solvent line as the internal standard. Mass spectra (MS) were performed on Agilent 1100 HPLC instrument coupled to a LC|MSD Trap mass spectrometer, in ESI(+) mode or APCI mode. Compounds showed a purity ≥95% as determined from the corresponding UV absorbance HPLC chromatogram.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.2" view="all">
                     <ce:label>4.2</ce:label>
                     <ce:section-title id="sectitle0090">Preparation of anilines <ce:bold>3a–c</ce:bold>
                     </ce:section-title>
                     <ce:section id="sec4.2.1" view="all">
                        <ce:label>4.2.1</ce:label>
                        <ce:section-title id="sectitle0095">3-Methyl-4-(4-methylpiperazin-1-yl)aniline (<ce:bold>3a</ce:bold>)</ce:section-title>
                        <ce:para id="p0150" view="all">A mixture of 1-fluoro-2-methyl-4-nitro-benzene (3.22 mmol), 1-methylpiperazine (3.63 mmol) and potassium carbonate (3.83 mmol) in dimethyl sulfoxide (4 ml) were stirred and heated to 100 °C for 4 h. The resultant reaction solution was cooled down to room temperature, added water (50 ml) to the reaction mixture, filtered off the solid residue, washed with water (50 ml), and air-dried to give the desired product of 1-methyl-4-(2-methyl-4-nitrophenyl-piperazine (<ce:bold>2a</ce:bold>)) as a brown solid, 77% yield. <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, Chloroform-d) <ce:italic>δ</ce:italic> 8.04 (d, <ce:italic>J</ce:italic> = 8.3 Hz, 2H), 7.01 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 3.07 (t, <ce:italic>J</ce:italic> = 4.8 Hz, 4H), 2.67–2.57 (m, 4H), 2.39 (s, 3H), 2.37 (s, 3H). [M+H]<ce:sup loc="post">+</ce:sup>, ESI <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 236.29. MW: 235.28 g/mol.</ce:para>
                        <ce:para id="p0155" view="all">Afterwards, the obtained compound, <ce:bold>2a</ce:bold> was hydrogenated. Pd/C (2.78 mmol) was added to a stirred solution of 1-methyl-4-(2-methyl-4-nitrophenyl-piperazine (5.53 mmol)) in methyl alcohol (15 ml) in N<ce:inf loc="post">2</ce:inf> atmosphere. Following this it was hydrogenated overnight by maintaining the reaction flask in an atmosphere of H<ce:inf loc="post">2</ce:inf> gas (balloon). The resultant was filtered thorough celite plate and concentrated under vacuum. The crude product was purified with silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>) to yield the desired product, <ce:bold>3a</ce:bold> as a brown solid, 87% yield. <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 6.74 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 6.38 (d, <ce:italic>J</ce:italic> = 2.7 Hz, 1H), 6.34 (dd, <ce:italic>J</ce:italic> = 8.4, 2.7 Hz, 1H), 4.61 (s, 2H), 2.68 (t, <ce:italic>J</ce:italic> = 4.8 Hz, 4H), 2.41 (s, 4H), 2.20 (s, 3H), 2.10 (2, 3H). [M+H]<ce:sup loc="post">+</ce:sup>, ESI <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 206.23. MW: 205.30 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.2" view="all">
                        <ce:label>4.2.2</ce:label>
                        <ce:section-title id="sectitle0100">4-(4-Methylpiperazin-1-yl)aniline (<ce:bold>3b</ce:bold>)</ce:section-title>
                        <ce:para id="p0160" view="all">A solution of 4-fluoronitrobenzene (7.1 mmol) and potassium carbonate (8.52 mol) in dimethyl sulfoxide (2 ml) was stirred at room temperature for 0.5 h 1-methylpiperazine (7.1 mmol) was added dropwise in the mixture solution. The resulting reaction mixture was stirred at room temperature for 6 h. The mixture was then poured into cold water. A yellow precipitate formed and was collected to give 1-methyl-4-(4-nitrophenyl)piperazine (<ce:bold>2b</ce:bold>), 93% yield. <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 8.16–8.09 (m, 2H), 6.86–6.80 (m, 2H), 3.53–3.46 (m, 4H), 2.70–2.60 (m, 2H), 2.42 (s, 3H). [M+H]<ce:sup loc="post">+</ce:sup>, APCI <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 222.1. MW: 221.26 g/mol.</ce:para>
                        <ce:para id="p0165" view="all">Following this it was hydrogenated using the same procedure as compound <ce:bold>2a</ce:bold> to yield the desired product, <ce:bold>3b</ce:bold> as a brown solid, 100% yield. <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) <ce:italic>δ</ce:italic> 6.69–6.64 (m, 2H), 6.50–6.44 (m, 2H), 4.53 (s, 1H), 2.91–2.85 (m, 4H), 2.45–2.37 (m, 4H). methyl proton overlaps with the solvent peak. [M+H]<ce:sup loc="post">+</ce:sup>, APCI <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 192.2. MW: 191.27 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.3" view="all">
                        <ce:label>4.2.3</ce:label>
                        <ce:section-title id="sectitle0105">4-(Morpholin-4-yl)aniline (<ce:bold>3c</ce:bold>)</ce:section-title>
                        <ce:para id="p0170" view="all">A mixture of 1-bromo-4-nitrobenzene (5.0 mmol), morpholine (5.0 mol) and potassium carbonate (6.0 mmol) in dimethyl sulfoxide (2 ml) were stirred and heated to 100 °C for 7 h. The resultant reaction solution was allowed to cool to room temperature. The mixture solution was extracted with EtOAc. The organic layer was collected, washed with brine, dried over Na<ce:inf loc="post">2</ce:inf>SO<ce:inf loc="post">4</ce:inf>, filtered, and dried under reduced pressure. The crude product was purified with silica-gel column chromatography (30% EtOAc/hexane) to give the desired product of 4-(4-nitrophenyl)morpholine, <ce:bold>2c</ce:bold> as a yellow solid, 47% yield. <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 8.18–8.09 (m, 2H), 6.86–6.79 (m, 2H), 3.88–3.82 (m, 4H), 3.39–3.31 (m, 4H).</ce:para>
                        <ce:para id="p0175" view="all">Following this compound <ce:bold>2c</ce:bold> was hydrogenated using the same procedure as compound <ce:bold>2a</ce:bold> to yield the desired product, <ce:bold>3c</ce:bold> as a purple solid, 97% yield. <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO) <ce:italic>δ</ce:italic> 6.70–6.65 (m, 2H), 6.51–6.47 (m, 2H), 4.57 (s, 2H), 3.71–3.65 (m, 4H), 2.91–2.84 (m, 4H). [M+H]<ce:sup loc="post">+</ce:sup>, APCI <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 179.1. MW: 178.23 g/mol.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.3" view="all">
                     <ce:label>4.3</ce:label>
                     <ce:section-title id="sectitle0110">General procedure for the preparation of intermediate compounds <ce:bold>4a–e</ce:bold>
                     </ce:section-title>
                     <ce:para id="p0180" view="all">DIPEA (0.86 mmol) was added to the solution of 2,4-dichloropyrimidine-5-carnonitrile (0.57 mmol) in DMF (0.5 ml) and stirred at room temperature for 10 min. A solution of aminobenzene reagent corresponding to desired product (0.57 mmol) in DMF (0.5 ml) was added dropwise to the reaction mixture and stirred for 1 h. The resultant was evaporated under vacuum and extracted with EtOAc. The organic layer was collected, washed with brine, dried over MgSO<ce:inf loc="post">4</ce:inf>, filtered, and dried under reduced pressure. <ce:bold>4c</ce:bold> was obtained from the reaction of <ce:bold>4b</ce:bold>, whereby substitution at the 2-position occurred.</ce:para>
                     <ce:section id="sec4.3.1" view="all">
                        <ce:label>4.3.1</ce:label>
                        <ce:section-title id="sectitle0115">2-[(2-Chloro-5-cyano-pyrimidin-4-yl)amino]benzamide (<ce:bold>4a</ce:bold>)</ce:section-title>
                        <ce:para id="p0185" view="all">2-aminobenzamide is used as an aminobenzene reagent, followed the general procedure and purified by silica-gel column chromatography (25%EtOAc/hexane) to yield <ce:bold>4a</ce:bold> as a yellow solid, yield 41%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 12.23 (s, 1H), 8.95 (s, 1H), 8.40 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 8.31 (s, 1H), 7.84 (dd, <ce:italic>J</ce:italic> = 7.9, 1.5 Hz, 1H), 7.80 (s, 1H), 7.58 (t, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 7.21 (t, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 273.67 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 273.68 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.2" view="all">
                        <ce:label>4.3.2</ce:label>
                        <ce:section-title id="sectitle0120">3-[(2-Chloro-5-cyano-pyrimidin-4-yl)amino]benzenesulfonamide (<ce:bold>4b</ce:bold>)</ce:section-title>
                        <ce:para id="p0190" view="all">2-Aminobenzensulfonamide is used as an aminobenzene reagent, followed the general procedure and purified by silica-gel column chromatography (10%EtOAc/hexane) to yield <ce:bold>4b</ce:bold> as a beige solid, yield 32%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.07 (s, 1H), 8.95 (s, 1H), 8.20 (s, 1H), 7.89–7.83 (m, 1H), 7.61–7.55 (m, 2H), 7.39 (s, 2H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 309.89 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 309.73 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.3" view="all">
                        <ce:label>4.3.3</ce:label>
                        <ce:section-title id="sectitle0125">3-[(4-Chloro-5-cyano-pyrimidin-4-yl)amino]benzenesulfonamide (<ce:bold>4c</ce:bold>)</ce:section-title>
                        <ce:para id="p0195" view="all">
                           <ce:bold>4c</ce:bold> was obtained as a side product from the reaction of <ce:bold>4b</ce:bold>, whereby substitution at the 2-position occurred. Purified by silica-gel column chromatography (10%EtOAc/hexane), a beige solid, yield 35%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 10.56 (s, 1H), 8.79 (s, 1H), 7.99 (t, <ce:italic>J</ce:italic> = 1.8 Hz, 1H), 7.80 (ddd, <ce:italic>J</ce:italic> = 8.1, 2.2, 1.1 Hz, 1H), 7.67 (dt, <ce:italic>J</ce:italic> = 7.9, 1.4 Hz, 1H), 7.60 (t, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 7.40 (s, 2H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 310.06 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 309.73 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.4" view="all">
                        <ce:label>4.3.4</ce:label>
                        <ce:section-title id="sectitle0130">2-Chloro-4-(3-methylsulfonylanilino)pyrimidine-5-carbonitrile (<ce:bold>4d</ce:bold>)</ce:section-title>
                        <ce:para id="p0200" view="all">3-(Methylsulfonyl)aniline hydrochloride is used as an aminobenzene reagent, followed the general procedure and purified by silica-gel column chromatography (5%MeOH/DCM) to yield <ce:bold>4d</ce:bold> as a yellow solid, yield 13%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.14 (s, 1H), 8.99 (s, 1H), 8.31 (s, 1H), 7.97 (dt, <ce:italic>J</ce:italic> = 6.4, 2.4 Hz, 1H), 7.69–7.62 (m, 2H), 3.21 (d, <ce:italic>J</ce:italic> = 1.4 Hz, 3H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 309.0 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 308.74 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.5" view="all">
                        <ce:label>4.3.5</ce:label>
                        <ce:section-title id="sectitle0135">
                           <ce:italic>N</ce:italic>-<ce:italic>tert</ce:italic>-butyl-3-[(2-chloro-5-cyano-pyrimidin-4-yl]benzenesulfonamide (<ce:bold>4e</ce:bold>)</ce:section-title>
                        <ce:para id="p0205" view="all">
                           <ce:italic>N-t</ce:italic>-butyl-3-aminobenesulfonamide is used as an aminobenzene reagent, followed the general procedure and purified by silica-gel column chromatography (0–5%MeOH/DCM) to yield <ce:bold>4e</ce:bold> as a beige solid, yield 30%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.06 (s, 1H), 8.94 (s, 1H), 8.21 (s, 1H), 7.85–7.81 (m, 1H), 7.56 (dd, <ce:italic>J</ce:italic> = 2.6, 1.4 Hz, 1H), 7.55 (d, <ce:italic>J</ce:italic> = 4.6 Hz, 2H), 1.12 (s, 9H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 366.08 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 365.84 g/mol.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.4" view="all">
                     <ce:label>4.4</ce:label>
                     <ce:section-title id="sectitle0140">General procedure for the preparation of intermediate compounds <ce:bold>4f</ce:bold>
                     </ce:section-title>
                     <ce:section id="sec4.4.1" view="all">
                        <ce:label>4.4.1</ce:label>
                        <ce:section-title id="sectitle0145">3-[(2-Chloro-5-methoxypyrimidin-4-yl)amino]benzene-1-sulfonamide (<ce:bold>4f</ce:bold>)</ce:section-title>
                        <ce:para id="p0210" view="all">3-aminobenzenesulfonamide (3.07 mmol) and DIPEA (8.38 mmol) was added to the mixture of 2,4-dichloro-5-methoxypyrimidine (2.79 mmol) in 1,4-dioxane (15 ml). The reaction mixture was stirred at 100 °C for 3 days. The solvent was evaporated under reduce pressure and extracted with EtOAc. The organic layer was collected, washed with brine, dried over MgSO<ce:inf loc="post">4</ce:inf>, filtered, and dried under reduced pressure. The crude product was purified with column chromatography (5% MeOH/DCM) to give the desired product, <ce:bold>4f</ce:bold> as a light yellow solid with a 22% yield, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.58 (s, 1H), 8.29–8.24 (m, 1H), 8.00 (s, 1H), 7.99–7.95 (m, 1H), 7.56–7.52 (m, 2H), 7.34 (s, 2H), 3.95 (s, 3H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 315.28 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 314.75 g/mol.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.5" view="all">
                     <ce:label>4.5</ce:label>
                     <ce:section-title id="sectitle0150">General procedure for the preparation of compounds <ce:bold>4g–4i</ce:bold>
                     </ce:section-title>
                     <ce:section id="sec4.5.1" view="all">
                        <ce:label>4.5.1</ce:label>
                        <ce:section-title id="sectitle0155">2-[(2-Chloropyrimidin-4-yl)amino]benzamide (<ce:bold>4g</ce:bold>)</ce:section-title>
                        <ce:para id="p0215" view="all">A mixture of 2,4-dichloropyrimidine and 2-aminobenzamide in 0.1 M HCl was stirred at 100 °C for 3 h. The precipitated obtained was filtered and the product was washed with water and recrystallized in methanol. The crystal product was collected and air-dried to give the desired intermediate compound, <ce:bold>4g</ce:bold> as a light green solid, with a 39% yield. <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.24 (s, 1H), 8.18 (dd, <ce:italic>J</ce:italic> = 11.3, 7.1 Hz, 3H), 7.76 (dd, <ce:italic>J</ce:italic> = 7.9, 1.5 Hz, 1H), 7.70 (s, 1H), 7.56–7.50 (m, 1H), 7.17 (td, <ce:italic>J</ce:italic> = 7.7, 1.1 Hz, 1H), 6.87 (d, <ce:italic>J</ce:italic> = 5.9 Hz, 1H). MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic>, 249.1 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 248.67 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.5.2" view="all">
                        <ce:label>4.5.2</ce:label>
                        <ce:section-title id="sectitle0160">3-[(2-Chloropyrimidin-4-yl)amino]benzenesulfonamide (<ce:bold>4h</ce:bold>)</ce:section-title>
                        <ce:para id="p0220" view="all">A solution of 2,4-dichloropyrimidine, 3-aminobenzenesulfonamide and DIPEA in <ce:italic>n</ce:italic>-BuOH was stirred at 110 °C for 13 h. The reaction mixture was cooled down to room temperature, concentrated under reduce pressure, and extracted with EtOAc. The organic layer was collected, washed with brine, dried over Na<ce:inf loc="post">2</ce:inf>SO<ce:inf loc="post">4</ce:inf>, filtered, and dried under reduced pressure. The crude product was purified with column chromatography (10% MeOH/DCM) to give the desired intermediate compound, <ce:bold>4h</ce:bold> as a beige solid, with a 48% yield. <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 10.31 (s, 1H), 8.23 (d, <ce:italic>J</ce:italic> = 5.9 Hz, 1H), 8.03 (d, <ce:italic>J</ce:italic> = 1.8 Hz, 1H), 7.90 (d, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 7.54 (tt, <ce:italic>J</ce:italic> = 4.6, 2.9 Hz, 2H), 6.80 (s, 1H). MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 285.1 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 284.72 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.5.3" view="all">
                        <ce:label>4.5.3</ce:label>
                        <ce:section-title id="sectitle0165">2-Chloro-<ce:italic>N</ce:italic>-(3-methylphenyl)pyrimidin-4-amine (<ce:bold>4i</ce:bold>)</ce:section-title>
                        <ce:para id="p0225" view="all">
                           <ce:bold>4i</ce:bold> was prepared using the same procedure as <ce:bold>4h</ce:bold>, with a 25 h of reaction time. A desired intermediate product <ce:bold>4i</ce:bold> was obtained as beige solid, with a 65% yield, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.94 (s, 1H), 8.13 (dd, <ce:italic>J</ce:italic> = 5.8, 3.2 Hz, 1H), 7.40 (d, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 7.34 (s, 1H), 7.25 (t, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 6.92 (d, <ce:italic>J</ce:italic> = 7.3 Hz, 1H), 6.75–6.72 (m, 1H), 2.30 (s, 3H), MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 220.1 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 219.67 g/mol.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.6" view="all">
                     <ce:label>4.6</ce:label>
                     <ce:section-title id="sectitle0170">General procedure for the synthesis of compound <ce:bold>1a</ce:bold>, <ce:bold>5a–d</ce:bold>
                     </ce:section-title>
                     <ce:para id="p0230" view="all">A chloro-intermediate compound (<ce:bold>4a–e</ce:bold>) (0.22 mmol) and DIPEA (0.33 mmol) were dissolved in DMF (0.5 ml). A solution of amino-intermediate compound (<ce:bold>3a–c</ce:bold>) (0.2 mmol) in DMF (0.5 ml) was then added dropwise into the solution. The reaction mixture was stirred at room temperature for 4 h. The resultant solution was concentrated under vacuum, and extracted with EtOAc. The organic layer was collected, washed with brine, dried over MgSO<ce:inf loc="post">4</ce:inf>, filtered, and dried under reduced pressure.</ce:para>
                     <ce:section id="sec4.6.1" view="all">
                        <ce:label>4.6.1</ce:label>
                        <ce:section-title id="sectitle0175">2-[[5-Cyano-2-[3-methyl-4-(4-methylpiperazin-1-yl)aniline]pyrimidin-4-yl]amino]benzamide (<ce:bold>1a</ce:bold>)</ce:section-title>
                        <ce:para id="p0235" view="all">Compound <ce:bold>3a</ce:bold> as the amino-intermediate and <ce:bold>4a</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>) to give the desired product, <ce:bold>1a</ce:bold> with a 25% yield as a beige solid. <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.67 (s, 1H), 9.51 (s, 1H), 8.49 (s, 1H), 8.39 (d, <ce:italic>J</ce:italic> = 8.5 Hz, 1H), 8.20 (s, 1H), 7.74 (dd, <ce:italic>J</ce:italic> = 7.9, 1.5 Hz, 1H), 7.69 (s, 1H), 7.33 (d, <ce:italic>J</ce:italic> = 2.5 Hz, 1H), 7.29–7.24 (m, 1H), 7.20 (t, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.03 (dd, <ce:italic>J</ce:italic> = 16.6, 8.2 Hz, 2H), 2.87 (t, <ce:italic>J</ce:italic> = 4.7 Hz, 4H), 2.25 (s, 3H), 2.24 (s, 3H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 443.13 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 442.53 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.6.2" view="all">
                        <ce:label>4.6.2</ce:label>
                        <ce:section-title id="sectitle0180">3-[[5-Cyano-2-[3-methyl-4-(4-methylpiperazin-1-yl)aniline]pyrimidin-4-yl]amino]benzenesulfonamide (<ce:bold>5a</ce:bold>)</ce:section-title>
                        <ce:para id="p0240" view="all">Compound <ce:bold>3a</ce:bold> as the amino-intermediate and <ce:bold>4b</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a beige solid, yield 23%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 10.07 (s, 1H), 9.38 (s, 1H), 8.50 (d, <ce:italic>J</ce:italic> = 1.3 Hz, 1H), 7.99 (d, <ce:italic>J</ce:italic> = 8.1 Hz, 1H), 7.90 (s, 1H), 7.45–7.40 (m, 1H), 7.31 (s, 3H), 7.27 (s, 2H), 7.02 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 1H), 2.85 (t, <ce:italic>J</ce:italic> = 4.7 Hz, 4H), 2.25 (s, 3H), 2.23 (s, 3H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 479.20 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 478.58 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.6.3" view="all">
                        <ce:label>4.6.3</ce:label>
                        <ce:section-title id="sectitle0185">3-[[5-Cyano-4-[3-methyl-4-(4-methylpiperazin-1-yl)aniline]pyrimidin-2-yl]amino]benzenesulfonamide (<ce:bold>5b</ce:bold>)</ce:section-title>
                        <ce:para id="p0245" view="all">Compound <ce:bold>3a</ce:bold> as the amino-intermediate and <ce:bold>4c</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a beige solid, yield 15%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.67 (s, 1H), 8.48 (s, 1H), 8.35 (d, <ce:italic>J</ce:italic> = 2.5 Hz, 1H), 7.71 (dt, <ce:italic>J</ce:italic> = 6.6, 2.3 Hz, 1H), 7.51 (dd, <ce:italic>J</ce:italic> = 5.0, 2.8 Hz, 2H), 7.30 (d, <ce:italic>J</ce:italic> = 7.0 Hz, 2H), 6.74 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 6.41 (d, <ce:italic>J</ce:italic> = 2.4 Hz, 1H), 6.34 (dd, <ce:italic>J</ce:italic> = 8.5, 2.6 Hz, 1H), 4.66 (s, 2H), 2.72 (d, <ce:italic>J</ce:italic> = 5.4 Hz, 4H), 2.16 (s, 3H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 479.12 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 478.58 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.6.4" view="all">
                        <ce:label>4.6.4</ce:label>
                        <ce:section-title id="sectitle0190">2-[3-Methyl-4-(4-methylpriperazin-1-yl)aniline]-4-(3-methylsulfonylanilino)pyrimidine-5-carbonitrile (<ce:bold>5c</ce:bold>)</ce:section-title>
                        <ce:para id="p0250" view="all">Compound <ce:bold>3a</ce:bold> as the amino-intermediate and <ce:bold>4d</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (0–10%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a yellow solid, yield 26%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 10.12 (s, 1H), 9.42 (s, 1H), 8.52 (s, 1H), 8.10 (dd, <ce:italic>J</ce:italic> = 8.0, 2.1 Hz, 1H), 7.98 (s, 1H), 7.50 (dt, <ce:italic>J</ce:italic> = 7.8, 1.3 Hz, 1H), 7.37 (s, 1H), 7.30 (d, <ce:italic>J</ce:italic> = 11.7 Hz, 2H), 7.02 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 3.11 (s, 3H), 2.85 (t, <ce:italic>J</ce:italic> = 4.6 Hz, 4H), 2.24 (s, 4H), 2.22 (s, 3H), 1.98 (s, 1H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 478.25 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 477.59 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.6.5" view="all">
                        <ce:label>4.6.5</ce:label>
                        <ce:section-title id="sectitle0195">
                           <ce:italic>N</ce:italic>-<ce:italic>tert</ce:italic>-butyl-3-(5-cyano-2-(3-methyl-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)benzene-sulfonamide (<ce:bold>5d</ce:bold>)</ce:section-title>
                        <ce:para id="p0255" view="all">Compound <ce:bold>3a</ce:bold> as the amino-intermediate and <ce:bold>4e</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a beige solid, yield 39%, <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 10.06 (s, 1H), 9.38 (s, 1H), 8.49 (s, 1H), 8.00 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 1H), 7.90 (s, 1H), 7.44–7.40 (m, 2H), 7.29 (d, <ce:italic>J</ce:italic> = 16.0 Hz, 3H), 7.02 (d, <ce:italic>J</ce:italic> = 8.5 Hz, 1H), 2.85 (t, <ce:italic>J</ce:italic> = 4.7 Hz, 4H), 2.25 (s, 3H), 2.22 (s, 3H), 1.09 (s, 9H). <ce:sup loc="pre">13</ce:sup>C NMR (101 MHz, DMSO) <ce:italic>δ</ce:italic> 164.71, 162.44, 160.56, 159.89, 158.68, 147.38, 144.62, 139.53, 133.06, 132.33, 122.64, 119.88, 119.15, 118.21, 117.79, 116.86, 116.39, 53.00, 50.92, 46.34, 35.66, 29.88, 21.80, 17.43, 13.93. MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 535.24 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 534.68 g/mol.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.7" view="all">
                     <ce:label>4.7</ce:label>
                     <ce:section-title id="sectitle0200">General procedure for the synthesis of compound <ce:bold>5e–g</ce:bold>
                     </ce:section-title>
                     <ce:section id="sec4.7.1" view="all">
                        <ce:label>4.7.1</ce:label>
                        <ce:section-title id="sectitle0205">2,4-bis(3-methylanilino)pyrimidine-5-carbonitrile (<ce:bold>5e</ce:bold>)</ce:section-title>
                        <ce:para id="p0260" view="all">3-Methylaniline (0.29 mmol) and DIPEA were added to a solution of 2,4-dichloropyrimidine-5-carbonitrile (0.29 mmol) in DMF (5 ml). The reaction mixture was stirred at room temperature for 4.5 h. The reaction mixture was then extracted with EtOAc. The organic layer was collected, washed with brine, dried over MgSO<ce:inf loc="post">4</ce:inf>, filtered, and dried under reduced pressure to yield the desired product, <ce:bold>5e</ce:bold> which disubstituted reaction at 2- and 4-position occurred, with a 50% yield as a white solid. <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.80 (s, 1H), 9.40 (s, 1H), 8.48 (s, 1H), 7.40 (s, 1H), 7.36 (q, <ce:italic>J</ce:italic> = 18.1, 10.4 Hz, 4H), 7.30 (t, <ce:italic>J</ce:italic> = 8.1 Hz, 1H), 7.24 (t, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.09 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 7.03 (d, <ce:italic>J</ce:italic> = 4.9 Hz, 3H), 6.99 (d, <ce:italic>J</ce:italic> = 7.7 Hz, 1H), 6.78 (d, <ce:italic>J</ce:italic> = 7.4 Hz, 1H), 2.28 (s, 3H), 2.14 (s, 3H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 316.31 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 315.38 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.7.2" view="all">
                        <ce:label>4.7.2</ce:label>
                        <ce:section-title id="sectitle0210">2,4-bis(3-methylanilino)pyrimidine-5-carboxamide (<ce:bold>5f</ce:bold>)</ce:section-title>
                        <ce:para id="p0265" view="all">
                           <ce:bold>5e</ce:bold> (0.09 mmol), hydrogen peroxide solution (0.86 mmol) and 1 M NaOH (0.17 mmol) in methyl alcohol (1 ml) were stirred to 40 °C for 24 h. The reaction mixture was concentrated under vacuum and extracted with EtOAc. The organic layer was collected, washed with brine, dried over MgSO<ce:inf loc="post">4</ce:inf>, filtered, and dried under reduced pressure. The crude product was purified by column chromatography (0–10%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>) to give <ce:bold>5f</ce:bold>, with a 48% yield as a beige solid. <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.52 (s, 1H), 9.55 (s, 1H), 8.69 (s, 1H), 7.99 (s, 1H), 7.51 (s, 2H), 7.47 (dd, <ce:italic>J</ce:italic> = 8.4, 2.1 Hz, 1H), 7.40 (s, 1H), 7.21 (t, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 7.13 (t, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 6.90 (dd, <ce:italic>J</ce:italic> = 7.4, 1.7 Hz, 1H), 6.83–6.79 (m, 1H), 2.27 (s, 3H), 2.22 (s, 3H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 334.13 [M+H]<ce:sup loc="post">+</ce:sup>. 333.40 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.7.3" view="all">
                        <ce:label>4.7.3</ce:label>
                        <ce:section-title id="sectitle0215">3-[2-Methoxy-5-[3-methyl-4-(4-methylpiperazin-1-yl)1-aniline]aniline]benzenesul-fonamide (<ce:bold>5g</ce:bold>)</ce:section-title>
                        <ce:para id="p0270" view="all">Compound <ce:bold>3a</ce:bold> was dissolved in tetrahydrofuran (0.4 ml) and treated with a solution of 1 M HCl (0.33 mmol) in ethyl ether. The mixture was stirred for 15 min and then concentrated under vacuum. The residue was then treated with <ce:bold>4f</ce:bold> (0.16 mmol) and 2-propanol (0.8 ml). The suspension was stirred at 100 °C for 5 days. The reaction mixture was added to a NaHCO<ce:inf loc="post">3</ce:inf> solution (10 ml) and extracted with EtOAc. The organic layer was collected, washed with brine, dried over MgSO<ce:inf loc="post">4</ce:inf>, filtered, and dried under reduced pressure to give the desired product, <ce:bold>5g</ce:bold> with a 91% yield as a beige solid. <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, Methanol-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">4</ce:inf>) <ce:italic>δ</ce:italic> 8.32 (t, <ce:italic>J</ce:italic> = 2.0 Hz, 1H), 8.04 (ddd, <ce:italic>J</ce:italic> = 8.2, 2.2, 1.0 Hz, 1H), 7.71 (s, 1H), 7.58 (dt, <ce:italic>J</ce:italic> = 7.9, 1.3 Hz, 1H), 7.46 (t, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.33–7.35 (m, 2H), 7.01 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 1H), 3.92 (s, 3H), 2.96 (t, <ce:italic>J</ce:italic> = 4.9 Hz, 4H), 2.76 (s, 4H), 2.46 (s, 3H), 2.26 (s, 3H). MS-ESI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 484.23 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 483.59 g/mol.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.8" view="all">
                     <ce:label>4.8</ce:label>
                     <ce:section-title id="sectitle0220">General procedure for the synthesis of compounds <ce:bold>5h–5r</ce:bold>
                     </ce:section-title>
                     <ce:para id="p0275" view="all">A chloro-intermediate (<ce:bold>4g–i)</ce:bold> (0.32 mmol) and amino-intermediate (<ce:bold>3a–c)</ce:bold> (0.32 mmol) were combined in a round bottom flask with 5 ml of isopropanol and catalytic amounts of TFA. The reaction mixture was stirred at 80 °C overnight. The reaction was then cooled down to room temperature, neutralized with 1 M NaOH, and evaporated under vacuum to give a crude product. The crude product was purified by silica-gel column chromatography to yield a desired product.</ce:para>
                     <ce:section id="sec4.8.1" view="all">
                        <ce:label>4.8.1</ce:label>
                        <ce:section-title id="sectitle0225">2-[(2-{[3-Methyl-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzamide (<ce:bold>5h</ce:bold>)</ce:section-title>
                        <ce:para id="p0280" view="all">Compound <ce:bold>3a</ce:bold> as the amino-intermediate and <ce:bold>4g</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5–10%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a beige solid, yield 67%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.10 (s, 1H), 9.05 (s, 1H), 8.57 (d, <ce:italic>J</ce:italic> = 8.3 Hz, 1H), 8.21 (s, 1H), 8.04 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.77–7.73 (m, 1H), 7.66 (s, 1H), 7.52 (d, <ce:italic>J</ce:italic> = 2.3 Hz, 1H), 7.46–7.37 (m, 2H), 7.04 (t, <ce:italic>J</ce:italic> = 7.0 Hz, 1H), 6.93 (s, 1H), 6.20 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 2.80 (t, <ce:italic>J</ce:italic> = 4.6 Hz, 4H), 2.23 (s, 3H), 2.20 (s, 3H). Another set of 4 protons is overlapped under water peak. MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic>, 418.3 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 417.52 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.2" view="all">
                        <ce:label>4.8.2</ce:label>
                        <ce:section-title id="sectitle0230">2-[(2-{[4-(4-Methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzamide (<ce:bold>5i</ce:bold>)</ce:section-title>
                        <ce:para id="p0285" view="all">Compound <ce:bold>3b</ce:bold> as the amino-intermediate and <ce:bold>4g</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a brown solid, yield 56%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.07 (s, 1H), 8.99 (s, 1H), 8.57 (d, <ce:italic>J</ce:italic> = 8.5 Hz, 1H), 8.20 (s, 1H), 8.01 (t, <ce:italic>J</ce:italic> = 5.2 Hz, 1H), 7.76 (dd, <ce:italic>J</ce:italic> = 7.9, 1.5 Hz, 1H), 7.65 (s, 1H), 7.52 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 7.44 (dd, <ce:italic>J</ce:italic> = 11.4, 4.3 Hz, 1H), 7.03 (dd, <ce:italic>J</ce:italic> = 11.1, 4.1 Hz, 1H), 6.87 (d, <ce:italic>J</ce:italic> = 9.1 Hz, 2H), 6.17 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 3.09–3.03 (m, 4H), 2.48–2.44 (m, 4H), 2.22 (s, 3H). MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic>, 404.3 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 403.49 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.3" view="all">
                        <ce:label>4.8.3</ce:label>
                        <ce:section-title id="sectitle0235">2-[(2-{[4-(Morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]benzamide (<ce:bold>5j</ce:bold>)</ce:section-title>
                        <ce:para id="p0290" view="all">Compound <ce:bold>3c</ce:bold> as the amino-intermediate and <ce:bold>4g</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a white solid, yield 11%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 11.08 (s, 1H), 9.02 (s, 1H), 8.57 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 8.21 (s, 1H), 8.03 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.76 (d, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 7.66 (s, 1H), 7.54 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 7.45 (t, <ce:italic>J</ce:italic> = 7.1 Hz, 1H), 7.04 (t, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 6.88 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 6.18 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 3.78–3.72 (m, 4H), 3.07–3.01 (m, 4H), MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic>, 391.3 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 390.45 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.4" view="all">
                        <ce:label>4.8.4</ce:label>
                        <ce:section-title id="sectitle0240">3-[(2-{[3-Methyl-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide (<ce:bold>5k</ce:bold>)</ce:section-title>
                        <ce:para id="p0295" view="all">Compound <ce:bold>3a</ce:bold> as the amino-intermediate and <ce:bold>4h</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a brown solid, yield 70%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.63 (s, 1H), 8.94 (s, 1H), 8.25 (d, <ce:italic>J</ce:italic> = 8.3 Hz, 1H), 8.03 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.89 (s, 1H), 7.45 (ddd, <ce:italic>J</ce:italic> = 7.7, 7.2, 1.5 Hz, 4H), 7.37 (s, 2H), 6.95 (d, <ce:italic>J</ce:italic> = 8.7 Hz, 1H), 6.21 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 2.80 (t, <ce:italic>J</ce:italic> = 4.5 Hz, 4H), 2.24 (s, 3H), 2.20 (s, 3H). <ce:sup loc="pre">13</ce:sup>C NMR (101 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 160.27, 159.58, 156.38, 145.46, 144.50, 140.64, 135.80, 131.82, 129.41, 122.46, 122.02, 118.84, 118.58, 117.85, 116.19, 98.65, 55.25, 51.56, 45.81, 40.19, 40.15, 39.98, 39.94, 39.73, 39.52, 39.31, 39.10, 38.89, 17.65. MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 454.2 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 453.57 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.5" view="all">
                        <ce:label>4.8.5</ce:label>
                        <ce:section-title id="sectitle0245">3-[(2-{[4-(4-methylprperazin-1-yl)phenyl]amino)pyrimidin-4-yl)amino]benzene-1-sulfonamide (<ce:bold>5l</ce:bold>)</ce:section-title>
                        <ce:para id="p0300" view="all">Compound <ce:bold>3b</ce:bold> as the amino-intermediate and <ce:bold>4h</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (10%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a beige solid, yield 62%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.60 (s, 1H), 8.89 (s, 1H), 8.19 (d, <ce:italic>J</ce:italic> = 8.3 Hz, 1H), 8.01 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.93 (s, 1H), 7.52 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 7.44 (ddd, <ce:italic>J</ce:italic> = 11.1, 7.9, 4.7 Hz, 2H), 7.37 (s, 1H), 6.88 (d, <ce:italic>J</ce:italic> = 9.1 Hz, 1H), 6.18 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 3.07 (t, <ce:italic>J</ce:italic> = 3.2 Hz 3H), 2.26 (s, 3H). MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 440.2 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 439.54 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.6" view="all">
                        <ce:label>4.8.6</ce:label>
                        <ce:section-title id="sectitle0250">3-[(2-{[4-(Morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]benzene-1-sulfonamide (<ce:bold>5m</ce:bold>)</ce:section-title>
                        <ce:para id="p0305" view="all">Compound <ce:bold>3c</ce:bold> as the amino-intermediate and <ce:bold>4h</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5–10%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a purple solid, yield 75%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.62 (s, 1H), 8.92 (s, 1H), 8.18 (d, <ce:italic>J</ce:italic> = 8.5 Hz, 1H), 8.01 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.93 (s, 1H), 7.53 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 2H), 7.47 (t, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 7.42 (dt, <ce:italic>J</ce:italic> = 7.8, 1.4 Hz, 1H), 7.37 (s, 2H), 6.88 (d, <ce:italic>J</ce:italic> = 9.1 Hz, 2H), 6.19 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 3.77–3.68 (m, 4H), 3.06–2.99 (m, 4H). <ce:sup loc="pre">13</ce:sup>C NMR (101 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 160.29, 159.69, 156.38, 146.10, 144.48, 140.64, 133.05, 129.37, 122.57, 120.76, 118.59, 116.18, 115.62, 98.46, 66.20, 49.35, 40.19, 40.15, 39.98, 39.94, 39.73, 39.52, 39.31, 39.10, 38.89. MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 427.2 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 426.50 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.7" view="all">
                        <ce:label>4.8.7</ce:label>
                        <ce:section-title id="sectitle0255">2-<ce:italic>N</ce:italic>-[4-(3,4-Dimethylpiperazin-1-yl)phenyl]-4-<ce:italic>N</ce:italic>-(3-methylphenyl)pyrimidine-2,4-diamine (<ce:bold>5n</ce:bold>)</ce:section-title>
                        <ce:para id="p0310" view="all">Compound <ce:bold>3a</ce:bold> as the amino-intermediate and <ce:bold>4i</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a brown solid, yield 80%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.20 (s, 1H), 8.90 (s, 1H), 7.96 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.48 (dd, <ce:italic>J</ce:italic> = 15.8, 8.0 Hz, 4H), 7.16 (t, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 6.92 (d, <ce:italic>J</ce:italic> = 8.5 Hz, 1H), 6.80 (d, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 6.15 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 2.78 (d, <ce:italic>J</ce:italic> = 4.3 Hz, 4H), 2.27 (s, 3H), 2.23 (s, 3H), 2.18 (s, 3H). <ce:sup loc="pre">13</ce:sup>C NMR (101 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 160.44, 159.71, 155.99, 145.29, 140.07, 137.77, 136.01, 131.78, 128.48, 122.65, 122.01, 120.26, 118.72, 117.79, 116.96, 98.28, 55.28, 51.63, 45.87, 40.20, 40.15, 39.99, 39.94, 39.73, 39.52, 39.31, 39.10, 38.89, 21.23, 17.58. MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 389.4 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 388.52 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.8" view="all">
                        <ce:label>4.8.8</ce:label>
                        <ce:section-title id="sectitle0260">4-<ce:italic>N</ce:italic>-(3-Methylphenyl)-2-<ce:italic>N</ce:italic>-[4-(4-methylpiperazin-1-yl)phenyl]pyrimidine-2,4-diamine (<ce:bold>5o</ce:bold>)</ce:section-title>
                        <ce:para id="p0315" view="all">Compound <ce:bold>3b</ce:bold> as the amino-intermediate and <ce:bold>4i</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a yellow solid, yield 82%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.18 (s, 1H), 8.85 (s, 1H), 7.94 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.59–7.47 (m, 3H), 7.43 (d, <ce:italic>J</ce:italic> = 6.6 Hz, 1H), 7.16 (t, <ce:italic>J</ce:italic> = 7.7 Hz, 1H), 6.85 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 2H), 6.79 (d, <ce:italic>J</ce:italic> = 7.1 Hz, 1H), 6.13 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 3.04 (t, <ce:italic>J</ce:italic> = 2.8 Hz 4H), 2.46 (t, <ce:italic>J</ce:italic> = 4.4 Hz, 4H), 2.27 (s, 3H), 2.22 (s, 3H). <ce:sup loc="pre">13</ce:sup>C NMR (101 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 160.45, 159.85, 155.99, 145.97, 140.11, 137.77, 132.96, 128.43, 122.57, 120.79, 120.19, 116.89, 115.84, 98.03, 54.73, 48.98, 45.79, 40.19, 40.15, 39.98, 39.94, 39.77, 39.73, 39.52, 39.31, 39.10, 38.89, 21.31. MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 375.3 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 374.49 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.9" view="all">
                        <ce:label>4.8.9</ce:label>
                        <ce:section-title id="sectitle0265">4-<ce:italic>N</ce:italic>-(3-Methylphenyl)-2-<ce:italic>N</ce:italic>-[4-(morpholin-4-yl)phenyl]pyrimidine-2,4-diamine (<ce:bold>5p</ce:bold>)</ce:section-title>
                        <ce:para id="p0320" view="all">Compound <ce:bold>3c</ce:bold> as the amino-intermediate and <ce:bold>4i</ce:bold> as the chloro-intermediate, following the general procedure. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a brown solid, yield 78%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.18 (s, 1H), 8.88 (s, 1H), 7.95 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.58–7.51 (m, 3H), 7.44 (d, <ce:italic>J</ce:italic> = 8.1 Hz, 1H), 7.16 (dd, <ce:italic>J</ce:italic> = 10.1, 5.5 Hz, 1H), 6.88–6.83 (m, 2H), 6.80 (d, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 6.14 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 3.78–3.69 (m, 4H), 3.05–2.97 (m, 4H). MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 362.3 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 361.45 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.10" view="all">
                        <ce:label>4.8.10</ce:label>
                        <ce:section-title id="sectitle0270">
                           <ce:italic>N</ce:italic>,<ce:italic>N</ce:italic>′-bis(3-methylphenyl)pyrimidine-2,4-diamine (<ce:bold>5q</ce:bold>)</ce:section-title>
                        <ce:para id="p0325" view="all">
                           <ce:bold>5q</ce:bold> was a by-product obtained from the double substitution reaction from the aniline used to produce <ce:bold>4i</ce:bold>. Purified by silica-gel column chromatography (10% MeOH/DCM), a beige solid, yield 2%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.25 (s, 1H), 9.05 (s, 1H), 7.99 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 7.53 (d, <ce:italic>J</ce:italic> = 7.1 Hz, 3H), 7.46 (s, 1H), 7.18 (t, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 7.14–7.07 (m, 1H), 6.82 (d, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 6.73 (d, <ce:italic>J</ce:italic> = 7.4 Hz, 1H), 6.20 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 2.28 (s, 3H), 2.24 (s, 3H), MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 291.2 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 290.37 g/mol.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.8.11" view="all">
                        <ce:label>4.8.11</ce:label>
                        <ce:section-title id="sectitle0275">2-<ce:italic>N</ce:italic>,4-<ce:italic>N</ce:italic>-bis[4-(morpholin-4-yl)phenyl]pyrimidine-2,4-diamine (<ce:bold>5r</ce:bold>)</ce:section-title>
                        <ce:para id="p0330" view="all">
                           <ce:bold>5r</ce:bold> was a by-product from the elimination of 2-aminobenzamide on the 2-position of compound <ce:bold>5j</ce:bold>. Purified by silica-gel column chromatography (5%MeOH/DCM, 1%NH<ce:inf loc="post">3</ce:inf>), a yellow solid, yield 20%, <ce:sup loc="pre">1</ce:sup>H NMR (400 MHz, DMSO-<ce:italic>d</ce:italic>
                           <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 10.13 (s, 1H), 9.02 (s, 1H), 8.51 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 1H), 8.06 (d, <ce:italic>J</ce:italic> = 5.6 Hz, 1H), 7.94 (dd, <ce:italic>J</ce:italic> = 8.0, 1.6 Hz, 1H), 7.60–7.49 (m, 3H), 7.15–7.08 (m, 1H), 6.86 (d, <ce:italic>J</ce:italic> = 9.1 Hz, 2H), 6.26 (d, <ce:italic>J</ce:italic> = 5.7 Hz, 1H), 3.76–3.71 (m, 4H), 3.06–2.99 (m, 4H), MS-APCI: <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic>, 434.3 [M+H]<ce:sup loc="post">+</ce:sup>. MW: 432.53 g/mol.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.9" view="all">
                     <ce:label>4.9</ce:label>
                     <ce:section-title id="sectitle0280">Biological assays</ce:section-title>
                     <ce:section id="sec4.9.1" view="all">
                        <ce:label>4.9.1</ce:label>
                        <ce:section-title id="sectitle0285">Anti-malarial activity</ce:section-title>
                        <ce:para id="p0335" view="all">Multidrug resistant <ce:italic>Plasmodium falciparum</ce:italic> (K1 strain) were cultivated as previously described <ce:cross-refs refid="bib43 bib52" id="crosrefs0070">[43,52]</ce:cross-refs>. Briefly, <ce:italic>P. falciparum</ce:italic> were cultivated in RPMI-1640 medium supplement with 25 mM HEPES, 25 mM NaHCO3, 10% heat-activated human serum and 3% erythrocytes. The culture is incubated at 37 °C in a humidified incubator with 3% CO<ce:inf loc="post">2</ce:inf> and daily passaged to fresh medium containing erythrocyte to maintain parasite growth. The <ce:italic>in vitro</ce:italic> antimalarial activity of the test peptides were tested against multidrug resistant <ce:italic>Plasmodium falciparum</ce:italic> (K1strain) using a semi-automated microdilution technique <ce:cross-ref refid="bib42" id="crosref0295">[42]</ce:cross-ref>. 200 μl of early ring state parasite mixture (1% parasitemia, 1.5% Hct) were added into each well of a 96 well plate. Then, 25 μl tested peptide were added in duplicate. Plates were incubated in CO<ce:inf loc="post">2</ce:inf> incubator for 24 h, then 25 μl of medium containing 0.5 μCi [<ce:sup loc="post">3</ce:sup>H] hypoxanthine (Perkin Elmer, USA) were added and incubated for 18–20 h. The levels of incorporated radioactive labeled hypoxanthine, indicating parasite growth, were determined by using the TopCount microplate scintillation counter (Packard, USA). Dihydroartemisinine chloroquine and mefloquine were used as positive control and 0.5% DMSO was used as negative controls. The antimalarial activity was expressed as the inhibitory concentration (IC<ce:inf loc="post">50</ce:inf>), representing the concentration of drug that reduced 50% of parasite growth. Data fitting was performed using SOFTMax Pro (Molecular Devices, USA).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.9.2" view="all">
                        <ce:label>4.9.2</ce:label>
                        <ce:section-title id="sectitle0290">Cytotoxicity</ce:section-title>
                        <ce:para id="p0340" view="all">The percent cytotoxicity against the Vero cell line (ATCC CCL-81) at 10 μM employed the method described by Hunt and co-workers <ce:cross-ref refid="bib44" id="crosref0300">[44]</ce:cross-ref>. The GFP-expressing Vero cell line was generated by stably transfecting the Vero cells with pEGFP-N1 plasmid Clontech and maintained in minimal essential medium supplemented with 10% heat inactivated fetal bovine serum, 2 mM <ce:small-caps>l</ce:small-caps>-glutamine, 1 mM sodium pyruvate, 1.5 g/L sodium bicarbonate, and 0.8 mg/ml geneticin at 37 °C in an incubator with 5% CO<ce:inf loc="post">2</ce:inf>. Vero cell suspension (45 μl, 3.3 × 10<ce:sup loc="post">4</ce:sup> cells/ml) was added into each well of 384-well plates containing 5 μL of test compounds. Plates were incubated in a CO2 incubator at 37 °C for 4 days. Fluorescence signals were measured using SpectraMaxM5 microplate reader (Molecular Devices, U.S.A.). Fluorescence signals were measured using SpectraMax M5 microplate reader (Molecular devices, U.S.A.) in the bottom-reading mode at the excitation and emission wavelengths of 530 and 590 nm. Ellipticine was used as the positive control and 0.5% DMSO as the negative control.</ce:para>
                        <ce:para id="p0345" view="all">Dose response curves for a subset of compounds were determined in Vero (ATCC CCL-81) and A549 (ATCC CCL-185) cells. The MTT based method described by Mosman el al was employed <ce:cross-ref refid="bib45" id="crosref0305">[45]</ce:cross-ref>. Cells were cultured in DMEM medium with 10% fetal bovine serum, 100 U/ml penicillin, and 100 U/ml streptomycin at 37 °C in a humidified atmosphere with 5% CO<ce:inf loc="post">2</ce:inf>. The cells were cultured in complete DMEM for 16–18 h, then cultured with compound for 72 h. Each well was charged with DMEM containing 3-[4,5-dimehyl-2-thiazolyl]-2,5- diphenyl-2<ce:italic>H</ce:italic>-tetrazolium bromide (MTT) (5 mg/ml in normal sodium), and then cells were incubated for 3 h. The medium was carefully decanted and 50 μl of dimethyl sulfoxide was added. The plate was shaken mechanically for 5 min, and then absorbance readings at a wavelength of 570 nm were performed on a Sunrise microplate reader (Tecan). Gefitinib was used as the positive control and 0.5% DMSO as the negative control.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.9.3" view="all">
                        <ce:label>4.9.3</ce:label>
                        <ce:section-title id="sectitle0295">Protein kinase activity</ce:section-title>
                        <ce:para id="p0350" view="all">All kinase assays were constituted and performed in a similar manner except for the following differences in reagents: For JAK2 kinase assays, the reaction contained 10 ng JAK2 enzyme, 0.1 mg/ml poly (Glu:Tyr) substrate and 0.1 mg/ml ATP. For JAK3 kinase assays, the reaction contained 3 ng JAK3 enzyme, 0.1 mg/ml poly (Glu:Tyr) substrate and 0.1 mg/ml ATP.</ce:para>
                        <ce:para id="p0355" view="all">Inhibition was determined by using Antibody Beacon™ Tyrosine Kinase Assay Kit (A-35725; Invitrogen, USA). For the EGFR kinase assay, the detection complex contained the following components in 1X kinase assay buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl<ce:inf loc="post">2</ce:inf>, 1 mM EGTA, 0.01% Brig and 2 mM DTT), 0.0267 mg/ml poly (Glu:Tyr), 6.7 nM anti-phosphotyrosine antibody, 0.33 nM Oregon Green 488 ligand and 0.5 mM ATP. To the reaction was added with 12.5 μl of test compounds and 12.5 μl of EGFR enzyme (3 ng enzyme/reaction). After that, 25 μl of the detection complex was added into each well. The mixture solution was analyzed for 1½ h at 30 °C in a fluorescence microplate reader using excitation at 485 nm and emission at 535 nm using an Infinite F200 fluorescence microplate reader (Tecan). The IC<ce:inf loc="post">50</ce:inf> data was obtained by fitting using Prism 6.0 (GraphPad Software Inc., San Diego, CA, USA). Erlotinib (EGFR) and compound-<ce:bold>7c</ce:bold> 
                           <ce:cross-ref refid="bib53" id="crosref0310">[53]</ce:cross-ref> (JAK2/3) were used as the positive control and 0.5% DMSO as the negative control.</ce:para>
                     </ce:section>
                  </ce:section>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment id="ack0010" view="all">
               <ce:section-title id="sectitle0300">Acknowledgments</ce:section-title>
               <ce:para id="p0360" view="all">The authors are grateful for financial support provided by the <ce:grant-sponsor id="gs1" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Faculty of Science at Kasetsart University</ce:grant-sponsor> (RFG1-5). MPG also acknowledges support from the <ce:grant-sponsor id="gs2" sponsor-id="http://dx.doi.org/10.13039/501100005621" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Kasetsart University Research and Development Institute</ce:grant-sponsor> (KURDI) and the <ce:grant-sponsor id="gs3" sponsor-id="http://dx.doi.org/10.13039/501100004396" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Thailand Research Fund</ce:grant-sponsor> (TRF, <ce:grant-number refid="gs3">RSA570068</ce:grant-number>). OP would like to acknowledge a scholarship provided by the <ce:grant-sponsor id="gs4" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Development and Promotion of Science and Technology Talents Project Grant</ce:grant-sponsor> (DPST). MPG and OP would like to thank Prof. S. Ruchiriwat and Dr P. Ploypradith for discussions and technical assistance.</ce:para>
            </ce:acknowledgment>
            <ce:appendices view="all">
               <ce:section id="appsec1" view="extended">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0305">Supplementary data</ce:section-title>
                  <ce:para id="p0365" view="all">
                     <ce:display>
                        <ce:e-component id="ec1">
                           <ce:link locator="mmc1" xlink:type="simple" xlink:href="pii:S0223523416307103/mmc1"/></ce:link>
                        </ce:e-component>
                     </ce:display>
                  </ce:para>
                  <ce:section id="appsec1.1" view="all">
                     <ce:section-title id="sectitle0310">Mol Files</ce:section-title>
                     <ce:para id="p0370" view="all">The following ZIP file contains the MOL files of the most important compounds referred to in this article.<ce:display>
                           <ce:e-component id="ec2">
                              <ce:caption id="cap0010">
                                 <ce:simple-para id="espara0010" view="all">MOL file. ZIP file containing the MOL files of the most important compounds in this article.</ce:simple-para>
                              </ce:caption>
                              <ce:link locator="mol" xlink:type="simple" xlink:href="pii:S0223523416307103/mol"/></ce:link>
                           </ce:e-component>
                        </ce:display>
                     </ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="appsec2" view="compact-standard">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0315">Supplementary data</ce:section-title>
                  <ce:para id="p0375" view="all">Supplementary data associated with this article can be found in the online version, at <ce:inter-ref xlink:href="doi:10.1016/j.ejmech.2016.08.055" id="intref0010" xlink:type="simple">http://dx.doi.org/10.1016/j.ejmech.2016.08.055</ce:inter-ref>. These data include MOL files and InChiKeys of the most important compounds described in this article.</ce:para>
               </ce:section>
            </ce:appendices>
         </body>
         <tail view="all">
            <ce:bibliography id="cebib0010" view="all">
               <ce:section-title id="sectitle0320">References</ce:section-title>
               <ce:bibliography-sec id="cebibsec0010" view="all">
                  <ce:bib-reference id="bib1">
                     <ce:label>[1]</ce:label>
                     <sb:reference id="sref1">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.H.</ce:given-name>
                                 <ce:surname>Miller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.C.</ce:given-name>
                                 <ce:surname>Ackerman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.-z.</ce:given-name>
                                 <ce:surname>Su</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.E.</ce:given-name>
                                 <ce:surname>Wellems</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>156</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib2">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="sref2">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Nagle</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Chatterjee</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>853</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib3">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="sref3">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:surname>WHO World Malaria Report</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2015</sb:date>
                              <sb:publisher>
                                 <sb:name>World Health Organization</sb:name>
                                 <sb:location>Geneva</sb:location>
                              </sb:publisher>
                           </sb:book>
                        </sb:host>
                        <sb:host>
                           <sb:e-host>
                              <ce:inter-ref xlink:href="http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/" id="intref0015" xlink:type="simple">http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/</ce:inter-ref>
                           </sb:e-host>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib4">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="sref4">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Biamonte</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Wanner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.G.</ce:given-name>
                                 <ce:surname>Le Roch</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>23</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2829</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib5">
                     <ce:label>[5]</ce:label>
                     <sb:reference id="sref5">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.H.</ce:given-name>
                                 <ce:surname>Sibley</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>347</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>373</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib6">
                     <ce:label>[6]</ce:label>
                     <sb:reference id="sref6">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.A.</ce:given-name>
                                 <ce:surname>Ashley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Dhorda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.M.</ce:given-name>
                                 <ce:surname>Fairhurst</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Amaratunga</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Lim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Suon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Sreng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Anderson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Mao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Sam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Sopha</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.M.</ce:given-name>
                                 <ce:surname>Chuor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Nguon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Sovannaroth</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Pukrittayakamee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Jittamala</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Chotivanich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Chutasmit</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Suchatsoonthorn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Runcharoen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.T.</ce:given-name>
                                 <ce:surname>Hien</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.T.</ce:given-name>
                                 <ce:surname>Thuy-Nhien</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.V.</ce:given-name>
                                 <ce:surname>Thanh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.H.</ce:given-name>
                                 <ce:surname>Phu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Htut</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.-T.</ce:given-name>
                                 <ce:surname>Han</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.H.</ce:given-name>
                                 <ce:surname>Aye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.A.</ce:given-name>
                                 <ce:surname>Mokuolu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.R.</ce:given-name>
                                 <ce:surname>Olaosebikan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.O.</ce:given-name>
                                 <ce:surname>Folaranmi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Mayxay</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Khanthavong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Hongvanthong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.N.</ce:given-name>
                                 <ce:surname>Newton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Onyamboko</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.I.</ce:given-name>
                                 <ce:surname>Fanello</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>Tshefu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Mishra</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Valecha</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.P.</ce:given-name>
                                 <ce:surname>Phyo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Nosten</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Tripura</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Borrmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Bashraheil</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Peshu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Faiz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Ghose</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Hossain</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Samad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.R.</ce:given-name>
                                 <ce:surname>Rahman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.M.</ce:given-name>
                                 <ce:surname>Hasan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Islam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Miotto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Amato</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>MacInnis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Stalker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.P.</ce:given-name>
                                 <ce:surname>Kwiatkowski</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Bozdech</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Jeeyapant</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.Y.</ce:given-name>
                                 <ce:surname>Cheah</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Sakulthaew</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chalk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Intharabut</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Silamut</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.J.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Vihokhern</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Kunasol</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Imwong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Tarning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.J.</ce:given-name>
                                 <ce:surname>Taylor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Yeung</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.J.</ce:given-name>
                                 <ce:surname>Woodrow</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Flegg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Das</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Smith</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Venkatesan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.V.</ce:given-name>
                                 <ce:surname>Plowe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Stepniewska</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Guerin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Dondorp</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.P.</ce:given-name>
                                 <ce:surname>Day</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.J.</ce:given-name>
                                 <ce:surname>White</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>N. Engl. J. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>371</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>411</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib7">
                     <ce:label>[7]</ce:label>
                     <sb:reference id="sref7">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.S.</ce:given-name>
                                 <ce:surname>Barnett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.K.</ce:given-name>
                                 <ce:surname>Guy</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chem. Rev.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>114</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>11221</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib8">
                     <ce:label>[8]</ce:label>
                     <sb:reference id="sref8">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.N.C.</ce:given-name>
                                 <ce:surname>Wells</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.H.</ce:given-name>
                                 <ce:surname>van Huijsduijnen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.C.</ce:given-name>
                                 <ce:surname>Van Voorhis</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Drug Discov.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>14</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>424</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib9">
                     <ce:label>[9]</ce:label>
                     <sb:reference id="sref9">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Vial</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Taramelli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.C.</ce:given-name>
                                 <ce:surname>Boulton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.A.</ce:given-name>
                                 <ce:surname>Ward</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Doerig</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Chibale</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Malar. J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>12</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>396</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib10">
                     <ce:label>[10]</ce:label>
                     <sb:reference id="sref10">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.R.</ce:given-name>
                                 <ce:surname>Derbyshire</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Zuzarte-Luís</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Magalhães</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Kato</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.C.</ce:given-name>
                                 <ce:surname>Sanschagrin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.V.</ce:given-name>
                                 <ce:surname>Miduturu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Mazitschek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Sliz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.M.</ce:given-name>
                                 <ce:surname>Mota</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.S.</ce:given-name>
                                 <ce:surname>Gray</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Clardy</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ChemBioChem</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>15</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1920</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib11">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="sref11">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>I.S.</ce:given-name>
                                 <ce:surname>Lucet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Tobin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Drewry</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.F.</ce:given-name>
                                 <ce:surname>Wilks</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Doerig</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Future Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>4</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2295</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib12">
                     <ce:label>[12]</ce:label>
                     <sb:reference id="sref12">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Leroy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Doerig</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Trends Pharmacol. Sci.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>29</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>241</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib13">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="sref13">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Morahan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Garcia-Bustos</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Biochem. Parasitol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>193</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>23</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib14">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="sref14">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Mbengue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bhattacharjee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Pandharkar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Estiu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.V.</ce:given-name>
                                 <ce:surname>Stahelin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.S.</ce:given-name>
                                 <ce:surname>Rizk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.L.</ce:given-name>
                                 <ce:surname>Njimoh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Ryan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Chotivanich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Nguon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ghorbal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.-J.</ce:given-name>
                                 <ce:surname>Lopez-Rubio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Pfrender</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Emrich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Mohandas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Dondorp</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Wiest</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Haldar</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nature</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>520</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>683</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib15">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="sref15">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ghidelli-Disse</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Lafuente-Monasterio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Waterson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Witty</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Younis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Paquet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.J.</ce:given-name>
                                 <ce:surname>Street</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Chibale</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.J.</ce:given-name>
                                 <ce:surname>Gamo-Benito</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Bantscheff</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Drewes</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Malar. J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib16">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="sref16">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Jirage</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Keenan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.C.</ce:given-name>
                                 <ce:surname>Waters</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Infect. Disord. Drug Targets</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>10</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>134</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib17">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="sref17">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Doerig</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Meijer</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Expert Opin. Ther. Targets</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>11</sb:volume-nr>
                              </sb:series>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>279</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib18">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="sref18">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Chavchich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Waters</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Top. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>12</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>456</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib19">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="sref19">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Ward</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Equinet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Packer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Doerig</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>BMC Genom.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>5</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>79</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib20">
                     <ce:label>[20]</ce:label>
                     <sb:reference id="sref20">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.J.</ce:given-name>
                                 <ce:surname>Crowther</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.K.</ce:given-name>
                                 <ce:surname>Hillesland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.R.</ce:given-name>
                                 <ce:surname>Keyloun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.C.</ce:given-name>
                                 <ce:surname>Reid</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Lafuente-Monasterio</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ghidelli-Disse</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.E.</ce:given-name>
                                 <ce:surname>Leonard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>He</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>Jones</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.M.</ce:given-name>
                                 <ce:surname>Krahn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Mo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.S.</ce:given-name>
                                 <ce:surname>Dasari</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.W.</ce:given-name>
                                 <ce:surname>Fox</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Boesche</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>El Bakkouri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.L.</ce:given-name>
                                 <ce:surname>Rivas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Leroy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Hui</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Drewes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.J.</ce:given-name>
                                 <ce:surname>Maly</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.C.</ce:given-name>
                                 <ce:surname>Van Voorhis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.K.</ce:given-name>
                                 <ce:surname>Ojo</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>PLoS One</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>11</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>e0149996</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib21">
                     <ce:label>[21]</ce:label>
                     <sb:reference id="sref21">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.M.</ce:given-name>
                                 <ce:surname>Chapman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.A.</ce:given-name>
                                 <ce:surname>Osborne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Wallace</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Birchall</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Bouloc</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.M.</ce:given-name>
                                 <ce:surname>Jones</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.H.</ce:given-name>
                                 <ce:surname>Ansell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.L.</ce:given-name>
                                 <ce:surname>Taylor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Clough</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Green</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Holder</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>57</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3570</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib22">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="sref22">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Large</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.A.</ce:given-name>
                                 <ce:surname>Osborne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Smiljanic-Hurley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.H.</ce:given-name>
                                 <ce:surname>Ansell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.M.</ce:given-name>
                                 <ce:surname>Jones</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.L.</ce:given-name>
                                 <ce:surname>Taylor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Clough</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Green</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Holder</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>23</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6019</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib23">
                     <ce:label>[23]</ce:label>
                     <sb:reference id="sref23">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.L.</ce:given-name>
                                 <ce:surname>Woodard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>Kathcart</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Terrell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Gerena</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lopez-Sanchez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.E.</ce:given-name>
                                 <ce:surname>Kyle</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>Bhattacharjee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.A.</ce:given-name>
                                 <ce:surname>Nichols</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Ellis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.T.</ce:given-name>
                                 <ce:surname>Prigge</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Geyer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.C.</ce:given-name>
                                 <ce:surname>Waters</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>46</sb:volume-nr>
                              </sb:series>
                              <sb:date>2003</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3877</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib24">
                     <ce:label>[24]</ce:label>
                     <sb:reference id="sref24">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Bouloc</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Large</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Smiljanic</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Whalley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.H.</ce:given-name>
                                 <ce:surname>Ansell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.D.</ce:given-name>
                                 <ce:surname>Edlin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Bryans</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5294</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib25">
                     <ce:label>[25]</ce:label>
                     <sb:reference id="sref25">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Z.A.</ce:given-name>
                                 <ce:surname>Knight</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.M.</ce:given-name>
                                 <ce:surname>Shokat</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>10</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>130</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib26">
                     <ce:label>[26]</ce:label>
                     <sb:reference id="sref26">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Gamo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Sanz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Vidal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>de Cozar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Alvarez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lavandera</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Vanderwall</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Green</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Kumar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Hasan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Brown</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Peishoff</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Cardon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Garcia-Bustos</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nature</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>465</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>305</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib27">
                     <ce:label>[27]</ce:label>
                     <sb:reference id="sref27">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Doerig</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Abdi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Bland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Eschenlauer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Dorin-Semblat</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Fennell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Halbert</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Holland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.-P.</ce:given-name>
                                 <ce:surname>Nivez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.-P.</ce:given-name>
                                 <ce:surname>Semblat</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Sicard</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Reininger</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Biochim. Biophys. Acta (BBA) Proteins Proteom.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>1804</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>604</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib28">
                     <ce:label>[28]</ce:label>
                     <sb:reference id="sref28">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.W.</ce:given-name>
                                 <ce:surname>Dymock</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.S.</ce:given-name>
                                 <ce:surname>See</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Expert Opin. Ther. Pat.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>23</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>449</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib29">
                     <ce:label>[29]</ce:label>
                     <sb:reference id="sref29">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.-W.</ce:given-name>
                                 <ce:surname>Qin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.-Y.</ce:given-name>
                                 <ce:surname>Sang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.-L.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.-Z.</ce:given-name>
                                 <ce:surname>Tian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.-X.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.-W.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Hui</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>95</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>174</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib30">
                     <ce:label>[30]</ce:label>
                     <sb:reference id="sref30">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kollareddy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Zheleva</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Dzubak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.S.</ce:given-name>
                                 <ce:surname>Brahmkshatriya</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Lepsik</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Hajduch</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Investig. New Drugs</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>30</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2411</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib31">
                     <ce:label>[31]</ce:label>
                     <sb:reference id="sref31">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lotharius</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.J.</ce:given-name>
                                 <ce:surname>Gamo-Benito</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Angulo-Barturen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Clark</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Connelly</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ferrer-Bazaga</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Parkinson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Viswanath</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Bandodkar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Rautela</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bharath</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Duffy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.M.</ce:given-name>
                                 <ce:surname>Avery</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Möhrle</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.K.</ce:given-name>
                                 <ce:surname>Guy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wells</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Malar. J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib32">
                     <ce:label>[32]</ce:label>
                     <sb:reference id="sref32">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ercan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.H.</ce:given-name>
                                 <ce:surname>Yun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Capelletti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.B.</ce:given-name>
                                 <ce:surname>Cortot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Chirieac</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.E.</ce:given-name>
                                 <ce:surname>Iacob</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Padera</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Engen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.K.</ce:given-name>
                                 <ce:surname>Wong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Eck</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.S.</ce:given-name>
                                 <ce:surname>Gray</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.A.</ce:given-name>
                                 <ce:surname>Janne</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nature</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>462</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1070</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib33">
                     <ce:label>[33]</ce:label>
                     <sb:reference id="sref33">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Song</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>He</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Koenig</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Shin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Noel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.Y.</ce:given-name>
                                 <ce:surname>Ling</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Feurstein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.H.</ce:given-name>
                                 <ce:surname>Ruiz</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.D.</ce:given-name>
                                 <ce:surname>Cameron</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.R.</ce:given-name>
                                 <ce:surname>Duckett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.M.</ce:given-name>
                                 <ce:surname>Kamenecka</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>MedChemComm</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>3</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>238</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib34">
                     <ce:label>[34]</ce:label>
                     <ce:other-ref id="sref34">
                        <ce:textref>Glenn Noronha, Chi Ching Mak, Jianguo Cao, Joel Renick, Andrew McPherson, Binqi Zeng, Ved P. Pathak, Daniel L. Lohse, John D. Hood, Soll, R. M, Bi-aryl meta-pyrimidine inhibitors of kinases, US 8604042 B2, TargeGen, Inc., San Diego, CA (US) 2011; vol. US 2011/0212077 A1.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib35">
                     <ce:label>[35]</ce:label>
                     <ce:other-ref id="sref35">
                        <ce:textref>Johnson, N. W., Bryan, D. L. Anthranilamide inhibitors of aurora kinase: US 20080182852 A1, Google Patents, 2008.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib36">
                     <ce:label>[36]</ce:label>
                     <sb:reference id="sref36">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Basu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Richters</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Rauh</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>23</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2767</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib37">
                     <ce:label>[37]</ce:label>
                     <sb:reference id="sref37">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Zuccotto</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Ardini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Casale</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Angiolini</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>53</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2681</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib38">
                     <ce:label>[38]</ce:label>
                     <sb:reference id="sref38">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.J.-L.</ce:given-name>
                                 <ce:surname>Liao</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>50</sb:volume-nr>
                              </sb:series>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>409</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib39">
                     <ce:label>[39]</ce:label>
                     <sb:reference id="sref39">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Martin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.-Y.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.R.</ce:given-name>
                                 <ce:surname>Lawrence</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Pireddu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Luo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Alam</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ozcan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Sebti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.J.</ce:given-name>
                                 <ce:surname>Lawrence</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Schönbrunn</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Chem. Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>698</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib40">
                     <ce:label>[40]</ce:label>
                     <sb:reference id="sref40">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.R.</ce:given-name>
                                 <ce:surname>Wood</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.T.</ce:given-name>
                                 <ce:surname>Truesdale</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.B.</ce:given-name>
                                 <ce:surname>McDonald</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Yuan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Hassell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.H.</ce:given-name>
                                 <ce:surname>Dickerson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Ellis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Pennisi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Horne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Lackey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.J.</ce:given-name>
                                 <ce:surname>Alligood</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.W.</ce:given-name>
                                 <ce:surname>Rusnak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.M.</ce:given-name>
                                 <ce:surname>Gilmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Shewchuk</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>64</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6652</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib41">
                     <ce:label>[41]</ce:label>
                     <sb:reference id="sref41">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Siu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Pastor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Barrett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Berry</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.S.</ce:given-name>
                                 <ce:surname>Blair</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Chang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.Z.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Eigenbrot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ghilardi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Gibbons</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>He</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.A.</ce:given-name>
                                 <ce:surname>Hurley</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Kenny</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Cyrus Khojasteh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Le</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Lyssikatos</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Magnuson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Pulk</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Tsui</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ultsch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Xiao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.-y.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Sampath</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>23</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5014</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib42">
                     <ce:label>[42]</ce:label>
                     <sb:reference id="sref42">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Desjardins</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Canfield</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Haynes</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chulay</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Antimicrob. Agents Chemother.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>16</sb:volume-nr>
                              </sb:series>
                              <sb:date>1979</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>710</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib43">
                     <ce:label>[43]</ce:label>
                     <sb:reference id="sref43">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Trager</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Jensen</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>193</sb:volume-nr>
                              </sb:series>
                              <sb:date>1976</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>673</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib44">
                     <ce:label>[44]</ce:label>
                     <sb:reference id="sref44">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Hunt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Jordan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>De Jesus</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.M.</ce:given-name>
                                 <ce:surname>Wurm</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Biotechnol. Bioeng.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>65</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>201</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib45">
                     <ce:label>[45]</ce:label>
                     <sb:reference id="sref45">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Mosmann</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Immunol. Methods</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>65</sb:volume-nr>
                              </sb:series>
                              <sb:date>1983</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>55</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib46">
                     <ce:label>[46]</ce:label>
                     <sb:reference id="sref46">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.Z.</ce:given-name>
                                 <ce:surname>Kamran</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Patil</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.P.</ce:given-name>
                                 <ce:surname>Gude</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>BioMed. Res. Int.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>2013</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>15</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib47">
                     <ce:label>[47]</ce:label>
                     <sb:reference id="sref47">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Hu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Hong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.-H.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Apoptosis</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1627</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib48">
                     <ce:label>[48]</ce:label>
                     <sb:reference id="sref48">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.W.</ce:given-name>
                                 <ce:surname>Ganster</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.S.</ce:given-name>
                                 <ce:surname>Taylor</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Shao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.A.</ce:given-name>
                                 <ce:surname>Geller</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>98</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>8638</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib49">
                     <ce:label>[49]</ce:label>
                     <sb:reference id="sref49">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.F.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zeng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Lei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>44</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1643</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib50">
                     <ce:label>[50]</ce:label>
                     <sb:reference id="sref50">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.-H.</ce:given-name>
                                 <ce:surname>Gao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.-Y.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.-H.</ce:given-name>
                                 <ce:surname>Yuan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.-Y.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Jiang</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Lung Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>73</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>366</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib51">
                     <ce:label>[51]</ce:label>
                     <sb:reference id="sref51">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>John</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Pharm. Des.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>9</sb:volume-nr>
                              </sb:series>
                              <sb:date>2003</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2593</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib52">
                     <ce:label>[52]</ce:label>
                     <sb:reference id="sref52">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Daengrot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Rukachaisirikul</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Tansakul</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Thongpanchang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Phongpaichit</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Bowornwiriyapan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Sakayaroj</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Nat. Prod.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>78</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>615</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib53">
                     <ce:label>[53]</ce:label>
                     <sb:reference id="sref53">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Forsyth</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.C.</ce:given-name>
                                 <ce:surname>Kearney</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.G.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.W.B.</ce:given-name>
                                 <ce:surname>Johnson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Aay</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Arcalas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.S.</ce:given-name>
                                 <ce:surname>Brown</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Chan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Du</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Epshteyn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Galan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.P.</ce:given-name>
                                 <ce:surname>Huynh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Ibrahim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Kane</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.S.</ce:given-name>
                                 <ce:surname>Koltun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Mann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.E.</ce:given-name>
                                 <ce:surname>Meyr</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.S.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.L.</ce:given-name>
                                 <ce:surname>Lewis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.T.</ce:given-name>
                                 <ce:surname>Noguchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Pack</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.H.</ce:given-name>
                                 <ce:surname>Ridgway</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Shi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.S.</ce:given-name>
                                 <ce:surname>Takeuchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Zu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.W.</ce:given-name>
                                 <ce:surname>Leahy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Nuss</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Aoyama</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Engst</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.B.</ce:given-name>
                                 <ce:surname>Gendreau</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Kassees</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.-H.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.-F.</ce:given-name>
                                 <ce:surname>Martini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Stout</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Tong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Woolfrey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                           </sb:authors>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>22</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>7653</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item></xocs:doc></originaltext></full-text-retrieval-response>